An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
Analogs and derivatives of atropine.
One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology.
Compounds containing the hexamethylenebis(trimethylammonium) cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents.
A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction, and may cause neuromuscular blockade. They are used as antidotes to organophosphorus poisoning as chlorides, iodides, methanesulfonates (mesylates), or other salts.
A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system.
The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).
A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.
Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.
Use of electric potential or currents to elicit biological responses.
Poisoning due to exposure to ORGANOPHOSPHORUS COMPOUNDS, such as ORGANOPHOSPHATES; ORGANOTHIOPHOSPHATES; and ORGANOTHIOPHOSPHONATES.
A group of compounds that are derivatives of beta-methylacetylcholine (methacholine).
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.
The interruption or removal of any part of the vagus (10th cranial) nerve. Vagotomy may be performed for research or for therapeutic purposes.
Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
The number of times the HEART VENTRICLES contract per unit of time, usually per minute.
Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
Agents counteracting or neutralizing the action of POISONS.
An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.
The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
The motor activity of the GASTROINTESTINAL TRACT.
Nerve fibers liberating acetylcholine at the synapse after an impulse.
The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
Bethanechol compounds are parasympathomimetic agents that directly stimulate muscarinic receptors, primarily used to treat urinary retention and nonobstructive bladder dysfunction by increasing bladder contractility and decreasing post-void residual volume.
Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
A non-hydrolyzed muscarinic agonist used as a research tool.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
The discharge of saliva from the SALIVARY GLANDS that keeps the mouth tissues moist and aids in digestion.
Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.
Drugs administered before an anesthetic to decrease a patient's anxiety and control the effects of that anesthetic.
A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies.
Drugs that bind to and activate cholinergic receptors.
An alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in URINARY INCONTINENCE, in MOTION SICKNESS, as an antispasmodic, and as a mydriatic and cycloplegic.
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.
A toxic alkaloid found in Amanita muscaria (fly fungus) and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.
An organophosphorus insecticide that inhibits ACETYLCHOLINESTERASE.
N-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in PLANTS.
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801)
A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.
That phase of a muscle twitch during which a muscle returns to a resting position.
An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent.
Bretylium compounds are pharmaceutical agents, primarily used in the treatment of life-threatening ventricular arrhythmias, that work by stabilizing the cardiac membrane and inhibiting the release of norepinephrine from sympathetic nerve endings.
A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.
A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.
A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.
Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).
An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.
The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651)
The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.
A histamine H2 receptor antagonist that is used as an anti-ulcer agent.
A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.
An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
The superior portion of the body of the stomach above the level of the cardiac notch.
A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.
A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors.
A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.
A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.
The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
The major nerves supplying sympathetic innervation to the abdomen. The greater, lesser, and lowest (or smallest) splanchnic nerves are formed by preganglionic fibers from the spinal cord which pass through the paravertebral ganglia and then to the celiac ganglia and plexuses. The lumbar splanchnic nerves carry fibers which pass through the lumbar paravertebral ganglia to the mesenteric and hypogastric ganglia.
Alkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc. Some act as cholinergic antagonists; most are very toxic; many are used medicinally.
Benzilates are organic compounds that contain the structure of benzil, characterized by two benzoyl groups (-COPh) bonded to a central carbon atom, and can be esters of benzilic acid with various alcohols.
The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.
A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.

Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus. (1/2794)

The effects of metrifonate, a second generation cholinesterase inhibitor, were examined on CA1 pyramidal neurons from hippocampal slices of young and aging rabbits using current-clamp, intracellular recording techniques. Bath perfusion of metrifonate (10-200 microM) dose-dependently decreased both postburst afterhyperpolarization (AHP) and spike frequency adaptation (accommodation) in neurons from young and aging rabbits (AHP: p < 0.002, young; p < 0.050, aging; accommodation: p < 0.024, young; p < 0.001, aging). These reductions were mediated by muscarinic cholinergic transmission, because they were blocked by addition of atropine (1 microM) to the perfusate. The effects of chronic metrifonate treatment (12 mg/kg for 3 weeks) on CA1 neurons of aging rabbits were also examined ex vivo. Neurons from aging rabbits chronically treated with metrifonate had significantly reduced spike frequency accommodation, compared with vehicle-treated rabbits. Chronic metrifonate treatment did not result in a desensitization to metrifonate ex vivo, because bath perfusion of metrifonate (50 microM) significantly decreased the AHP and accommodation in neurons from both chronically metrifonate- and vehicle-treated aging rabbits. We propose that the facilitating effect of chronic metrifonate treatment on acquisition of hippocampus-dependent tasks such as trace eyeblink conditioning by aging subjects may be caused by this increased excitability of CA1 pyramidal neurons.  (+info)

Indirect evidence for cholinergic inhibition of intestinal bicarbonate absorption in humans. (2/2794)

BACKGROUND: The aim of the study was to test the hypothesis that in the fasting state, proximal intestinal HCO3- absorption, which depends on villus Na+/H+ exchanger activity, is tonically inhibited by a cholinergic atropine sensitive mechanism. SUBJECTS: The experiments were performed in 34 healthy volunteers and in eight patients with intestinal villus atrophy. METHODS: HCO3- absorption was measured with a modified triple lumen perfusion technique in the distal duodenum, the most proximal portion of the small intestine. The study was designed to compensate for the inhibitory effects of atropine on intestinal motor activity. RESULTS: Atropine had three effects on HCO3- transport: it reduced HCO3- concentration at the proximal aspiration site, it displaced the relation between HCO3- concentration and HCO3- absorption to the left, and it induced a significant acidification of the perfusate at the distal aspiration site. The magnitude of the stimulatory effect on HCO3- absorption was similar to the difference between patients with intestinal villus atrophy and healthy controls. CONCLUSION: The data suggest that, in the fasting state, duodenal HCO3- absorption, which depends on villus Na+/H+ exchanger activity, may be tonically inhibited by an atropine sensitive cholinergic mechanism.  (+info)

Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo. (3/2794)

In five fasting, conscious dogs, we compared the prokinetic action of two selective 5-hydroxytryptamine-4 (5-HT4) receptor agonists with low affinity for 5-HT3 receptors ML10302 (2-piperidinoethyl 4-amino-5-chloro-2-methoxybenzoate) and SR59768 (2-[(3S)-3-hydroxypiperidino]ethyl 4-amino-5-chloro-2-methoxybenzoate) in the duodenum and jejunum, using cisapride as a reference compound. Heart rate and rate-corrected QT (QTc) also were monitored to assess whether or not the cardiac effects of cisapride are shared by other 5-HT4 receptor agonists. Both ML10302 and SR59768 dose-dependently stimulated spike activity in the duodenum with similar potencies (dose range, 3-300 nmol/kg i.v.; ED50 values: 24 and 23 nmol/kg i.v., respectively), mimicking the effect of cisapride (30-3000 nmol/kg i.v.). The maximal effect was achieved with the dose of 100 nmol/kg i.v. for both compounds. Similar findings were obtained in the jejunum. Atropine and GR125487 (1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl-methyl 5-fluoro-2-methoxy-1H-indole-3-carboxylate, selective 5-HT4 receptor antagonist), at doses having no effect per se, antagonized intestinal prokinesia by maximal doses of ML10302 and SR59768. Neither ML10302 nor SR59768 had any effect on heart rate or QTc at any of the doses tested, whereas cisapride, at the highest dose (3000 nmol/kg), induced tachycardia and lengthened the QTC (p <.01). In conclusion, ML10302 and SR59768 share with cisapride a similar prokinetic action in the canine duodenum and jejunum in vivo. This effect is mediated by pathways involving activation of 5-HT4 and muscarinic receptors. Unlike cisapride, which induces tachycardia and prolongs the QTc by a mechanism probably unrelated to 5-HT4 receptor activation, ML10302 and SR59768 are devoid of cardiac effects in this model.  (+info)

Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release. (4/2794)

1. The aims of this study were to determine: (1) whether vasoactive intestinal peptide (VIP) regulates cholinergic and 'sensory-efferent' (tachykininergic) 35SO4 labelled mucus output in ferret trachea in vitro, using a VIP antibody, (2) the class of potassium (K+) channel involved in VIP-regulation of cholinergic neural secretion using glibenclamide (an ATP-sensitive K+ (K(ATP)) channel inhibitor), iberiotoxin (a large conductance calcium activated K+ (BK(ca)) channel blocker), and apamin (a small conductance K(ca) (SK(ca)) channel blocker), and (3) the effect of VIP on cholinergic neurotransmission using [3H]-choline overflow as a marker for acetylcholine (ACh) release. 2. Exogenous VIP (1 and 10 microM) alone increased 35SO4 output by up to 53% above baseline, but suppressed (by up to 80% at 1 microM) cholinergic and tachykininergic neural secretion without altering secretion induced by ACh or substance P (1 microM each). Endogenous VIP accounted for the minor increase in non-adrenergic, non-cholinergic (NANC), non-tachykininergic neural secretion, which was compatible with the secretory response of exogenous VIP. 3. Iberiotoxin (3 microM), but not apamin (1 microM) or glibenclamide (0.1 microM), reversed the inhibition by VIP (10 nM) of cholinergic neural secretion. 4. Both endogenous VIP (by use of the VIP antibody; 1:500 dilution) and exogenous VIP (0.1 microM), the latter by 34%, inhibited ACh release from cholinergic nerve terminals and this suppression was completely reversed by iberiotoxin (0.1 microM). 5. We conclude that, in ferret trachea in vitro, endogenous VIP has dual activity whereby its small direct stimulatory action on mucus secretion is secondary to its marked regulation of cholinergic and tachykininergic neurogenic mucus secretion. Regulation is via inhibition of neurotransmitter release, consequent upon opening of BK(Ca) channels. In the context of neurogenic mucus secretion, we propose that VIP joins NO as a neurotransmitter of i-NANC nerves in ferret trachea.  (+info)

Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine. (5/2794)

1. Immunized BP2 mice developed an acute bronchoconstriction in vivo and airway muscle contraction in vitro in response to ovalbumin (OA) and these contractions were dose dependent. 2. Methysergide or atropine inhibited OA-induced bronchoconstriction in vivo and airway muscle contraction in vitro. 3. Neostigmine potentiated the OA-induced bronchoconstriction in vivo and airway muscle contraction in vitro of BP2 mice. This potentiation was markedly reduced by the administration of methysergide or atropine and when the two antagonists were administered together, the responses were completely inhibited. 4. Neostigmine also potentiated the serotonin (5-HT)- and acetylcholine (ACh)-induced bronchoconstriction and this potentiation was significantly reversed by atropine. 5. These results indicate that OA provokes a bronchoconstriction in immunized BP2 mice by stimulating the release of 5-HT, which in turn acts via the cholinergic mediator, ACh.  (+info)

Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells. (6/2794)

We recently reported that clozapine behaves as a partial agonist at the cloned human m4 muscarinic receptor subtype. In the present study, we investigated whether the drug could elicit similar effects at the cloned human m1, m2, and m3 muscarinic receptor subtypes expressed in the Chinese hamster ovary (CHO) cells. Clozapine elicited a concentration-dependent stimulation of [3H]inositol phosphates accumulation in CHO cells expressing either the m1 or the m3 receptor subtype. Moreover, clozapine inhibited forskolin-stimulated cyclic AMP accumulation and enhanced [35S] GTP gamma S binding to membrane G proteins in CHO cells expressing the m2 receptor. These agonist effects of clozapine were antagonized by atropine. The intrinsic activity of clozapine was lower than that of the full cholinergic agonist carbachol, and, when the compounds were combined, clozapine potently reduced the receptor responses to carbachol. These data indicate that clozapine behaves as a partial agonist at different muscarinic receptor subtypes and may provide new hints for understanding the receptor mechanisms underlying the antipsychotic efficacy of the drug.  (+info)

Wavelet transform to quantify heart rate variability and to assess its instantaneous changes. (7/2794)

Heart rate variability is a recognized parameter for assessing autonomous nervous system activity. Fourier transform, the most commonly used method to analyze variability, does not offer an easy assessment of its dynamics because of limitations inherent in its stationary hypothesis. Conversely, wavelet transform allows analysis of nonstationary signals. We compared the respective yields of Fourier and wavelet transforms in analyzing heart rate variability during dynamic changes in autonomous nervous system balance induced by atropine and propranolol. Fourier and wavelet transforms were applied to sequences of heart rate intervals in six subjects receiving increasing doses of atropine and propranolol. At the lowest doses of atropine administered, heart rate variability increased, followed by a progressive decrease with higher doses. With the first dose of propranolol, there was a significant increase in heart rate variability, which progressively disappeared after the last dose. Wavelet transform gave significantly better quantitative analysis of heart rate variability than did Fourier transform during autonomous nervous system adaptations induced by both agents and provided novel temporally localized information.  (+info)

Assessment of cardiac sympathetic regulation by respiratory-related arterial pressure variability in the rat. (8/2794)

1. Mechanical ventilation evokes a corresponding arterial pressure variability (APV) which is decreased by beta-adrenoceptor antagonism. Therefore, in this study we set out to determine whether the respiratory-related APV can be used to assess cardiac sympathetic tone. 2. Computer-generated broad-band mechanical ventilation (0-3 Hz) was applied to Sprague-Dawley rats that had been anaesthetized with ketamine and paralysed with pancuronium. APV and its relationship to lung volume variability (LVV-APV) was systematically quantified with auto- or cross-spectral frequency domain analysis. 3. APV and LVV-APV transfer magnitudes between 0.5 and 1.5 Hz showed dose-dependent suppression by propranolol from 0.01 to 1 mg kg-1, while the static value of arterial pressure remained unchanged. Stroke volume variability, assessed by the use of a pulse contour method, exhibited a similar pattern of suppression by propranolol. In contrast, heart rate variability was not lowered with propranolol. 4. The effect of propranolol on respiratory-related APV persisted even in the presence of combined alpha-adrenoceptor and muscarinic receptor blockade by phentolamine and atropine. 5. The frequency range of 0.5-1.0 Hz was optimal for LVV-APV transfer magnitude to correlate with cardiac sympathetic tone. 6. We conclude that respiratory-related APV may provide a valid assessment of cardiac sympathetic regulation which is independent of parasympathetic and vascular sympathetic influences in ketamine-anaesthetized and positive pressure-ventilated rats.  (+info)

Atropine is an anticholinergic drug that blocks the action of the neurotransmitter acetylcholine in the central and peripheral nervous system. It is derived from the belladonna alkaloids, which are found in plants such as deadly nightshade (Atropa belladonna), Jimson weed (Datura stramonium), and Duboisia spp.

In clinical medicine, atropine is used to reduce secretions, increase heart rate, and dilate the pupils. It is often used before surgery to dry up secretions in the mouth, throat, and lungs, and to reduce salivation during the procedure. Atropine is also used to treat certain types of nerve agent and pesticide poisoning, as well as to manage bradycardia (slow heart rate) and hypotension (low blood pressure) caused by beta-blockers or calcium channel blockers.

Atropine can have several side effects, including dry mouth, blurred vision, dizziness, confusion, and difficulty urinating. In high doses, it can cause delirium, hallucinations, and seizures. Atropine should be used with caution in patients with glaucoma, prostatic hypertrophy, or other conditions that may be exacerbated by its anticholinergic effects.

Muscarinic antagonists, also known as muscarinic receptor antagonists or parasympatholytics, are a class of drugs that block the action of acetylcholine at muscarinic receptors. Acetylcholine is a neurotransmitter that plays an important role in the parasympathetic nervous system, which helps to regulate various bodily functions such as heart rate, digestion, and respiration.

Muscarinic antagonists work by binding to muscarinic receptors, which are found in various organs throughout the body, including the eyes, lungs, heart, and gastrointestinal tract. By blocking the action of acetylcholine at these receptors, muscarinic antagonists can produce a range of effects depending on the specific receptor subtype that is affected.

For example, muscarinic antagonists may be used to treat conditions such as chronic obstructive pulmonary disease (COPD) and asthma by relaxing the smooth muscle in the airways and reducing bronchoconstriction. They may also be used to treat conditions such as urinary incontinence or overactive bladder by reducing bladder contractions.

Some common muscarinic antagonists include atropine, scopolamine, ipratropium, and tiotropium. It's important to note that these drugs can have significant side effects, including dry mouth, blurred vision, constipation, and confusion, especially when used in high doses or for prolonged periods of time.

Parasympatholytics are a type of medication that blocks the action of the parasympathetic nervous system. The parasympathetic nervous system is responsible for the body's rest and digest response, which includes slowing the heart rate, increasing intestinal and glandular activity, and promoting urination and defecation.

Parasympatholytics work by selectively binding to muscarinic receptors, which are found in various organs throughout the body, including the heart, lungs, and digestive system. By blocking these receptors, parasympatholytics can cause a range of effects, such as an increased heart rate, decreased glandular secretions, and reduced intestinal motility.

Some common examples of parasympatholytics include atropine, scopolamine, and ipratropium. These medications are often used to treat conditions such as bradycardia (slow heart rate), excessive salivation, and gastrointestinal cramping or diarrhea. However, because they can have significant side effects, parasympatholytics are typically used only when necessary and under the close supervision of a healthcare provider.

Atropine derivatives are a class of drugs that are chemically related to atropine, an alkaloid found in the nightshade family of plants. These drugs have anticholinergic properties, which means they block the action of the neurotransmitter acetylcholine in the body.

Atropine derivatives can be used for a variety of medical purposes, including:

1. Treating motion sickness and vertigo
2. Dilating the pupils during eye examinations
3. Reducing saliva production during surgical procedures
4. Treating certain types of poisoning, such as organophosphate or nerve gas poisoning
5. Managing symptoms of some neurological disorders, such as Parkinson's disease and myasthenia gravis

Some examples of atropine derivatives include hyoscyamine, scopolamine, and ipratropium. These drugs can have side effects, including dry mouth, blurred vision, constipation, difficulty urinating, and rapid heartbeat. They should be used with caution and under the supervision of a healthcare provider.

Muscarinic receptors are a type of G protein-coupled receptor (GPCR) that bind to the neurotransmitter acetylcholine. They are found in various organ systems, including the nervous system, cardiovascular system, and respiratory system. Muscarinic receptors are activated by muscarine, a type of alkaloid found in certain mushrooms, and are classified into five subtypes (M1-M5) based on their pharmacological properties and signaling pathways.

Muscarinic receptors play an essential role in regulating various physiological functions, such as heart rate, smooth muscle contraction, glandular secretion, and cognitive processes. Activation of M1, M3, and M5 muscarinic receptors leads to the activation of phospholipase C (PLC) and the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), which increase intracellular calcium levels and activate protein kinase C (PKC). Activation of M2 and M4 muscarinic receptors inhibits adenylyl cyclase, reducing the production of cAMP and modulating ion channel activity.

In summary, muscarinic receptors are a type of GPCR that binds to acetylcholine and regulates various physiological functions in different organ systems. They are classified into five subtypes based on their pharmacological properties and signaling pathways.

Hexamethonium compounds are a type of ganglionic blocker, which are medications that block the transmission of nerve impulses at the ganglia ( clusters of nerve cells) in the autonomic nervous system. These compounds contain hexamethonium as the active ingredient, which is a compound with the chemical formula C16H32N2O4.

Hexamethonium works by blocking the nicotinic acetylcholine receptors at the ganglia, which prevents the release of neurotransmitters and ultimately inhibits the transmission of nerve impulses. This can have various effects on the body, depending on which part of the autonomic nervous system is affected.

Hexamethonium compounds were once used to treat hypertension (high blood pressure), but they are rarely used today due to their numerous side effects and the availability of safer and more effective medications. Some of the side effects associated with hexamethonium include dry mouth, blurred vision, constipation, difficulty urinating, and dizziness upon standing.

Acetylcholine is a neurotransmitter, a type of chemical messenger that transmits signals across a chemical synapse from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. It is involved in both peripheral and central nervous system functions.

In the peripheral nervous system, acetylcholine acts as a neurotransmitter at the neuromuscular junction, where it transmits signals from motor neurons to activate muscles. Acetylcholine also acts as a neurotransmitter in the autonomic nervous system, where it is involved in both the sympathetic and parasympathetic systems.

In the central nervous system, acetylcholine plays a role in learning, memory, attention, and arousal. Disruptions in cholinergic neurotransmission have been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, and myasthenia gravis.

Acetylcholine is synthesized from choline and acetyl-CoA by the enzyme choline acetyltransferase and is stored in vesicles at the presynaptic terminal of the neuron. When a nerve impulse arrives, the vesicles fuse with the presynaptic membrane, releasing acetylcholine into the synapse. The acetylcholine then binds to receptors on the postsynaptic membrane, triggering a response in the target cell. Acetylcholine is subsequently degraded by the enzyme acetylcholinesterase, which terminates its action and allows for signal transduction to be repeated.

Pralidoxime compounds are a type of antidote used to treat poisoning from organophosphate nerve agents and pesticides. These compounds work by reactivating the acetylcholinesterase enzyme, which is inhibited by organophosphates. This helps to restore the normal functioning of the nervous system and can save lives in cases of severe poisoning.

Pralidoxime is often used in combination with atropine, another antidote that blocks the effects of excess acetylcholine at muscarinic receptors. Together, these compounds can help to manage the symptoms of organophosphate poisoning and prevent long-term neurological damage.

It is important to note that pralidoxime must be administered as soon as possible after exposure to organophosphates, as its effectiveness decreases over time. This makes rapid diagnosis and treatment crucial in cases of suspected nerve agent or pesticide poisoning.

Physostigmine is a medication that belongs to a class of drugs called cholinesterase inhibitors. It works by blocking the breakdown of a neurotransmitter called acetylcholine, which is important for communication between nerves and muscles. This results in an increase in acetylcholine levels in the body, improving nerve impulse transmission and helping to restore normal muscle function.

Physostigmine is used in the treatment of certain medical conditions that are caused by a deficiency of acetylcholine, such as myasthenia gravis, which is a neuromuscular disorder characterized by weakness and fatigue of the muscles. It may also be used to reverse the effects of certain medications that block the action of acetylcholine, such as anticholinergics, which are sometimes used in anesthesia or to treat conditions like Parkinson's disease.

It is important to note that physostigmine should only be used under the close supervision of a healthcare provider, as it can have serious side effects if not used properly.

Parasympathomimetics are substances or drugs that mimic the actions of the parasympathetic nervous system. The parasympathetic nervous system is one of the two branches of the autonomic nervous system, which regulates involuntary physiological functions. It is responsible for the "rest and digest" response, and its neurotransmitter is acetylcholine.

Parasympathomimetic drugs work by either directly stimulating muscarinic receptors or increasing the availability of acetylcholine in the synaptic cleft. These drugs can have various effects on different organs, depending on the specific receptors they target. Some common effects include decreasing heart rate and contractility, reducing respiratory rate, constricting pupils, increasing glandular secretions (such as saliva and sweat), stimulating digestion, and promoting urination and defecation.

Examples of parasympathomimetic drugs include pilocarpine, which is used to treat dry mouth and glaucoma; bethanechol, which is used to treat urinary retention and neurogenic bladder; and neostigmine, which is used to treat myasthenia gravis and reverse the effects of non-depolarizing muscle relaxants.

The Parasympathetic Nervous System (PNS) is the part of the autonomic nervous system that primarily controls vegetative functions during rest, relaxation, and digestion. It is responsible for the body's "rest and digest" activities including decreasing heart rate, lowering blood pressure, increasing digestive activity, and stimulating sexual arousal. The PNS utilizes acetylcholine as its primary neurotransmitter and acts in opposition to the Sympathetic Nervous System (SNS), which is responsible for the "fight or flight" response.

The vagus nerve, also known as the 10th cranial nerve (CN X), is the longest of the cranial nerves and extends from the brainstem to the abdomen. It has both sensory and motor functions and plays a crucial role in regulating various bodily functions such as heart rate, digestion, respiratory rate, speech, and sweating, among others.

The vagus nerve is responsible for carrying sensory information from the internal organs to the brain, and it also sends motor signals from the brain to the muscles of the throat and voice box, as well as to the heart, lungs, and digestive tract. The vagus nerve helps regulate the body's involuntary responses, such as controlling heart rate and blood pressure, promoting relaxation, and reducing inflammation.

Dysfunction in the vagus nerve can lead to various medical conditions, including gastroparesis, chronic pain, and autonomic nervous system disorders. Vagus nerve stimulation (VNS) is a therapeutic intervention that involves delivering electrical impulses to the vagus nerve to treat conditions such as epilepsy, depression, and migraine headaches.

Carbachol is a cholinergic agonist, which means it stimulates the parasympathetic nervous system by mimicking the action of acetylcholine, a neurotransmitter that is involved in transmitting signals between nerves and muscles. Carbachol binds to both muscarinic and nicotinic receptors, but its effects are more pronounced on muscarinic receptors.

Carbachol is used in medical treatments to produce miosis (pupil constriction), lower intraocular pressure, and stimulate gastrointestinal motility. It can also be used as a diagnostic tool to test for certain conditions such as Hirschsprung's disease.

Like any medication, carbachol can have side effects, including sweating, salivation, nausea, vomiting, diarrhea, bradycardia (slow heart rate), and bronchoconstriction (narrowing of the airways in the lungs). It should be used with caution and under the supervision of a healthcare professional.

Mydriatics are medications that cause mydriasis, which is the dilation of the pupil. These drugs work by blocking the action of the muscarinic receptors in the iris, leading to relaxation of the circular muscle and constriction of the radial muscle, resulting in pupil dilation. Mydriatics are often used in eye examinations to facilitate examination of the interior structures of the eye. Commonly used mydriatic agents include tropicamide, phenylephrine, and cyclopentolate. It is important to note that mydriatics can have side effects such as blurred vision, photophobia, and accommodation difficulties, so patients should be advised accordingly.

Smooth muscle, also known as involuntary muscle, is a type of muscle that is controlled by the autonomic nervous system and functions without conscious effort. These muscles are found in the walls of hollow organs such as the stomach, intestines, bladder, and blood vessels, as well as in the eyes, skin, and other areas of the body.

Smooth muscle fibers are shorter and narrower than skeletal muscle fibers and do not have striations or sarcomeres, which give skeletal muscle its striped appearance. Smooth muscle is controlled by the autonomic nervous system through the release of neurotransmitters such as acetylcholine and norepinephrine, which bind to receptors on the smooth muscle cells and cause them to contract or relax.

Smooth muscle plays an important role in many physiological processes, including digestion, circulation, respiration, and elimination. It can also contribute to various medical conditions, such as hypertension, gastrointestinal disorders, and genitourinary dysfunction, when it becomes overactive or underactive.

Pirenzepine is a medication that belongs to a class of drugs called anticholinergics or parasympatholytics. It works by blocking the action of acetylcholine, a neurotransmitter in the body, on certain types of muscarinic receptors.

Pirenzepine is primarily used to treat peptic ulcers and gastroesophageal reflux disease (GERD) by reducing the production of stomach acid. It may also be used to manage symptoms of irritable bowel syndrome, such as abdominal pain and diarrhea.

The medication is available in the form of tablets or gel for topical application. Side effects of pirenzepine may include dry mouth, blurred vision, constipation, dizziness, and difficulty urinating. It should be used with caution in people with glaucoma, benign prostatic hyperplasia, or other conditions that may be exacerbated by anticholinergic drugs.

It is important to note that this definition is for informational purposes only and should not be taken as medical advice. Always consult with a healthcare professional before starting any new medication.

Neostigmine is a medication that belongs to a class of drugs called cholinesterase inhibitors. It works by blocking the breakdown of acetylcholine, a neurotransmitter in the body, leading to an increase in its levels at the neuromuscular junction. This helps to improve muscle strength and tone by enhancing the transmission of nerve impulses to muscles.

Neostigmine is primarily used in the treatment of myasthenia gravis, a neurological disorder characterized by muscle weakness and fatigue. It can also be used to reverse the effects of non-depolarizing muscle relaxants administered during surgery. Additionally, neostigmine may be used to diagnose and manage certain conditions that cause decreased gut motility or urinary retention.

It is important to note that neostigmine should be used under the close supervision of a healthcare professional due to its potential side effects, which can include nausea, vomiting, diarrhea, increased salivation, sweating, and muscle cramps. In some cases, it may also cause respiratory distress or cardiac arrhythmias.

I'm sorry for any confusion, but "autonomic agents" is not a medical term or concept that has a specific definition in the field of medicine. The term "autonomic" refers to the part of the nervous system that regulates involuntary physiological functions, such as heart rate, digestion, and respiratory rate. The term "agents," on the other hand, is often used in computer science and artificial intelligence to refer to software entities that can act on behalf of a user or another entity.

Therefore, "autonomic agents" might refer to software programs that are designed to regulate physiological functions autonomously, but this would be more related to the field of biomedical engineering or artificial intelligence than to medicine itself. If you have more context or information about where you encountered this term, I may be able to provide a more specific answer.

Electric stimulation, also known as electrical nerve stimulation or neuromuscular electrical stimulation, is a therapeutic treatment that uses low-voltage electrical currents to stimulate nerves and muscles. It is often used to help manage pain, promote healing, and improve muscle strength and mobility. The electrical impulses can be delivered through electrodes placed on the skin or directly implanted into the body.

In a medical context, electric stimulation may be used for various purposes such as:

1. Pain management: Electric stimulation can help to block pain signals from reaching the brain and promote the release of endorphins, which are natural painkillers produced by the body.
2. Muscle rehabilitation: Electric stimulation can help to strengthen muscles that have become weak due to injury, illness, or surgery. It can also help to prevent muscle atrophy and improve range of motion.
3. Wound healing: Electric stimulation can promote tissue growth and help to speed up the healing process in wounds, ulcers, and other types of injuries.
4. Urinary incontinence: Electric stimulation can be used to strengthen the muscles that control urination and reduce symptoms of urinary incontinence.
5. Migraine prevention: Electric stimulation can be used as a preventive treatment for migraines by applying electrical impulses to specific nerves in the head and neck.

It is important to note that electric stimulation should only be administered under the guidance of a qualified healthcare professional, as improper use can cause harm or discomfort.

Organophosphate (OP) poisoning refers to the toxic effects that occur after exposure to organophosphate compounds, which are commonly used as pesticides, nerve agents, and plasticizers. These substances work by irreversibly inhibiting acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine in the nervous system. As a result, excessive accumulation of acetylcholine leads to overstimulation of cholinergic receptors, causing a wide range of symptoms.

The severity and type of symptoms depend on the dose, duration, and route of exposure (inhalation, ingestion, or skin absorption). The primary manifestations of organophosphate poisoning are:

1. Muscarinic effects: Excess acetylcholine at muscarinic receptors in the parasympathetic nervous system results in symptoms such as narrowed pupils (miosis), increased salivation, lacrimation, sweating, bronchorrhea (excessive respiratory secretions), diarrhea, bradycardia (decreased heart rate), and hypotension.
2. Nicotinic effects: Overstimulation of nicotinic receptors at the neuromuscular junction leads to muscle fasciculations, weakness, and paralysis. This can also cause tachycardia (increased heart rate) and hypertension.
3. Central nervous system effects: OP poisoning may result in headache, dizziness, confusion, seizures, coma, and respiratory depression.

Treatment for organophosphate poisoning includes decontamination, supportive care, and administration of antidotes such as atropine (to block muscarinic effects) and pralidoxime (to reactivate acetylcholinesterase). Delayed treatment can lead to long-term neurological damage or even death.

Methacholine compounds are medications that are used as a diagnostic tool to help identify and confirm the presence of airway hyperresponsiveness in patients with respiratory symptoms such as cough, wheeze, or shortness of breath. These compounds act as bronchoconstrictors, causing narrowing of the airways in individuals who have heightened sensitivity and reactivity of their airways, such as those with asthma.

Methacholine is a synthetic derivative of acetylcholine, a neurotransmitter that mediates nerve impulse transmission in the body. When inhaled, methacholine binds to muscarinic receptors on the smooth muscle surrounding the airways, leading to their contraction and narrowing. The degree of bronchoconstriction is then measured to assess the patient's airway responsiveness.

It is important to note that methacholine compounds are not used as therapeutic agents but rather as diagnostic tools in a controlled medical setting under the supervision of healthcare professionals.

I must clarify that the term "Guinea Pigs" is not typically used in medical definitions. However, in colloquial or informal language, it may refer to people who are used as the first to try out a new medical treatment or drug. This is known as being a "test subject" or "in a clinical trial."

In the field of scientific research, particularly in studies involving animals, guinea pigs are small rodents that are often used as experimental subjects due to their size, cost-effectiveness, and ease of handling. They are not actually pigs from Guinea, despite their name's origins being unclear. However, they do not exactly fit the description of being used in human medical experiments.

Muscle contraction is the physiological process in which muscle fibers shorten and generate force, leading to movement or stability of a body part. This process involves the sliding filament theory where thick and thin filaments within the sarcomeres (the functional units of muscles) slide past each other, facilitated by the interaction between myosin heads and actin filaments. The energy required for this action is provided by the hydrolysis of adenosine triphosphate (ATP). Muscle contractions can be voluntary or involuntary, and they play a crucial role in various bodily functions such as locomotion, circulation, respiration, and posture maintenance.

Propranolol is a medication that belongs to a class of drugs called beta blockers. Medically, it is defined as a non-selective beta blocker, which means it blocks the effects of both epinephrine (adrenaline) and norepinephrine (noradrenaline) on the heart and other organs. These effects include reducing heart rate, contractility, and conduction velocity, leading to decreased oxygen demand by the myocardium. Propranolol is used in the management of various conditions such as hypertension, angina pectoris, arrhythmias, essential tremor, anxiety disorders, and infants with congenital heart defects. It may also be used to prevent migraines and reduce the risk of future heart attacks. As with any medication, it should be taken under the supervision of a healthcare provider due to potential side effects and contraindications.

Guanethidine is an antihypertensive medication that belongs to the class of drugs known as ganglionic blockers or autonomic nervous system (ANS) inhibitors. It works by blocking the action of certain chemicals (neurotransmitters) in the body, which results in decreased blood pressure and heart rate.

Guanethidine is not commonly used today due to its side effects and the availability of safer and more effective antihypertensive medications. Its medical definition can be stated as:

A synthetic antihypertensive agent that acts by depleting norepinephrine stores in postganglionic adrenergic neurons, thereby blocking their activity. Guanethidine is used primarily in the treatment of hypertension and occasionally in the management of sympathetic nervous system-mediated conditions such as essential tremor or neurogenic pain.

Glycopyrrolate is an anticholinergic medication that works by blocking the action of acetylcholine, a chemical messenger in the body. It reduces the secretions of certain organs and is used to treat various conditions such as peptic ulcers, reducing saliva production during surgical procedures, preventing motion sickness, and managing some symptoms of Parkinson's disease.

In medical terms, glycopyrrolate is a competitive antagonist of muscarinic acetylcholine receptors. It has a particular affinity for the M1, M2, and M3 receptor subtypes. By blocking these receptors, it inhibits the parasympathetic nervous system's effects on various organs, leading to decreased glandular secretions (such as saliva, sweat, and gastric acid), slowed heart rate, and relaxation of smooth muscles in the digestive tract and bronchioles.

Glycopyrrolate is available in oral, intravenous, and topical forms and should be used under the supervision of a healthcare professional due to its potential side effects, including dry mouth, blurred vision, dizziness, drowsiness, and urinary retention.

A vagotomy is a surgical procedure that involves cutting or blocking the vagus nerve, which is a parasympathetic nerve that runs from the brainstem to the abdomen and helps regulate many bodily functions such as heart rate, gastrointestinal motility, and digestion. In particular, vagotomy is often performed as a treatment for peptic ulcers, as it can help reduce gastric acid secretion.

There are several types of vagotomy procedures, including:

1. Truncal vagotomy: This involves cutting the main trunks of the vagus nerve as they enter the abdomen. It is a more extensive procedure that reduces gastric acid secretion significantly but can also lead to side effects such as delayed gastric emptying and diarrhea.
2. Selective vagotomy: This involves cutting only the branches of the vagus nerve that supply the stomach, leaving the rest of the nerve intact. It is a less extensive procedure that reduces gastric acid secretion while minimizing side effects.
3. Highly selective vagotomy (HSV): Also known as parietal cell vagotomy, this involves cutting only the branches of the vagus nerve that supply the acid-secreting cells in the stomach. It is a highly targeted procedure that reduces gastric acid secretion while minimizing side effects such as delayed gastric emptying and diarrhea.

Vagotomy is typically performed using laparoscopic or open surgical techniques, depending on the patient's individual needs and the surgeon's preference. While vagotomy can be effective in treating peptic ulcers, it is not commonly performed today due to the development of less invasive treatments such as proton pump inhibitors (PPIs) that reduce gastric acid secretion without surgery.

Muscarinic agonists are a type of medication that binds to and activates muscarinic acetylcholine receptors, which are found in various organ systems throughout the body. These receptors are activated naturally by the neurotransmitter acetylcholine, and when muscarinic agonists bind to them, they mimic the effects of acetylcholine.

Muscarinic agonists can have a range of effects on different organ systems, depending on which receptors they activate. For example, they may cause bronchodilation (opening up of the airways) in the respiratory system, decreased heart rate and blood pressure in the cardiovascular system, increased glandular secretions in the gastrointestinal and salivary systems, and relaxation of smooth muscle in the urinary and reproductive systems.

Some examples of muscarinic agonists include pilocarpine, which is used to treat dry mouth and glaucoma, and bethanechol, which is used to treat urinary retention. It's important to note that muscarinic agonists can also have side effects, such as sweating, nausea, vomiting, and diarrhea, due to their activation of receptors in various organ systems.

Phentolamine is a non-selective alpha-blocker drug, which means it blocks both alpha-1 and alpha-2 receptors. It works by relaxing the muscle around blood vessels, which increases blood flow and lowers blood pressure. Phentolamine is used medically for various purposes, including the treatment of high blood pressure, the diagnosis and treatment of pheochromocytoma (a tumor that releases hormones causing high blood pressure), and as an antidote to prevent severe hypertension caused by certain medications or substances. It may also be used in diagnostic tests to determine if a patient's blood pressure is reactive to drugs, and it can be used during some surgical procedures to help lower the risk of hypertensive crises.

Phentolamine is available in two forms: an injectable solution and oral tablets. The injectable form is typically administered by healthcare professionals in a clinical setting, while the oral tablets are less commonly used due to their short duration of action and potential for causing severe drops in blood pressure. As with any medication, phentolamine should be taken under the supervision of a healthcare provider, and patients should follow their doctor's instructions carefully to minimize the risk of side effects and ensure the drug's effectiveness.

Heart rate is the number of heartbeats per unit of time, often expressed as beats per minute (bpm). It can vary significantly depending on factors such as age, physical fitness, emotions, and overall health status. A resting heart rate between 60-100 bpm is generally considered normal for adults, but athletes and individuals with high levels of physical fitness may have a resting heart rate below 60 bpm due to their enhanced cardiovascular efficiency. Monitoring heart rate can provide valuable insights into an individual's health status, exercise intensity, and response to various treatments or interventions.

Cholinesterase reactivators are a type of medication used to reverse the effects of certain types of poisoning, particularly organophosphate and carbamate pesticides, as well as nerve agents. These chemicals work by inhibiting the enzyme acetylcholinesterase, which normally breaks down the neurotransmitter acetylcholine in the body. This can lead to an overaccumulation of acetylcholine and result in symptoms such as muscle weakness, seizures, and respiratory failure.

Cholinesterase reactivators, also known as oximes, work by reactivating the inhibited enzyme and allowing it to resume its normal function. The most commonly used cholinesterase reactivator is pralidoxime (2-PAM), which is often administered in combination with atropine to treat organophosphate poisoning.

It's important to note that cholinesterase reactivators are not effective against all types of nerve agents or pesticides, and their use should be determined by a medical professional based on the specific type of poisoning involved. Additionally, these medications can have side effects and should only be administered under medical supervision.

Cholinesterase inhibitors are a class of drugs that work by blocking the action of cholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine in the body. By inhibiting this enzyme, the levels of acetylcholine in the brain increase, which can help to improve symptoms of cognitive decline and memory loss associated with conditions such as Alzheimer's disease and other forms of dementia.

Cholinesterase inhibitors are also used to treat other medical conditions, including myasthenia gravis, a neuromuscular disorder that causes muscle weakness, and glaucoma, a condition that affects the optic nerve and can lead to vision loss. Some examples of cholinesterase inhibitors include donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon).

It's important to note that while cholinesterase inhibitors can help to improve symptoms in some people with dementia, they do not cure the underlying condition or stop its progression. Side effects of these drugs may include nausea, vomiting, diarrhea, and increased salivation. In rare cases, they may also cause seizures, fainting, or cardiac arrhythmias.

Bethanechol is a parasympathomimetic drug, which means it stimulates the parasympathetic nervous system. This system is responsible for regulating many automatic functions in the body, including digestion and urination. Bethanechol works by causing the smooth muscles of the bladder to contract, which can help to promote urination in people who have difficulty emptying their bladder completely due to certain medical conditions such as surgery, spinal cord injury, or multiple sclerosis.

The medical definition of 'Bethanechol' is:

A parasympathomimetic agent that stimulates the muscarinic receptors of the autonomic nervous system, causing contraction of smooth muscle and increased secretion of exocrine glands. It is used to treat urinary retention and associated symptoms, such as those caused by bladder-neck obstruction due to prostatic hypertrophy or neurogenic bladder dysfunction. Bethanechol may also be used to diagnose urinary tract obstruction and to test the integrity of the bladder's innervation.

An antidote is a substance that can counteract the effects of a poison or toxin. It works by neutralizing, reducing, or eliminating the harmful effects of the toxic substance. Antidotes can be administered in various forms such as medications, vaccines, or treatments. They are often used in emergency situations to save lives and prevent serious complications from poisoning.

The effectiveness of an antidote depends on several factors, including the type and amount of toxin involved, the timing of administration, and the individual's response to treatment. In some cases, multiple antidotes may be required to treat a single poisoning incident. It is important to note that not all poisons have specific antidotes, and in such cases, supportive care and symptomatic treatment may be necessary.

Examples of common antidotes include:

* Naloxone for opioid overdose
* Activated charcoal for certain types of poisoning
* Digoxin-specific antibodies for digoxin toxicity
* Fomepizole for methanol or ethylene glycol poisoning
* Dimercaprol for heavy metal poisoning.

Tetrodotoxin (TTX) is a potent neurotoxin that is primarily found in certain species of pufferfish, blue-ringed octopuses, and other marine animals. It blocks voltage-gated sodium channels in nerve cell membranes, leading to muscle paralysis and potentially respiratory failure. TTX has no known antidote, and medical treatment focuses on supportive care for symptoms. Exposure can occur through ingestion, inhalation, or skin absorption, depending on the route of toxicity.

The ileum is the third and final segment of the small intestine, located between the jejunum and the cecum (the beginning of the large intestine). It plays a crucial role in nutrient absorption, particularly for vitamin B12 and bile salts. The ileum is characterized by its thin, lined walls and the presence of Peyer's patches, which are part of the immune system and help surveil for pathogens.

Gastrointestinal motility refers to the coordinated muscular contractions and relaxations that propel food, digestive enzymes, and waste products through the gastrointestinal tract. This process involves the movement of food from the mouth through the esophagus into the stomach, where it is mixed with digestive enzymes and acids to break down food particles.

The contents are then emptied into the small intestine, where nutrients are absorbed, and the remaining waste products are moved into the large intestine for further absorption of water and electrolytes and eventual elimination through the rectum and anus.

Gastrointestinal motility is controlled by a complex interplay between the autonomic nervous system, hormones, and local reflexes. Abnormalities in gastrointestinal motility can lead to various symptoms such as bloating, abdominal pain, nausea, vomiting, diarrhea, or constipation.

Cholinergic fibers are nerve cell extensions (neurons) that release the neurotransmitter acetylcholine at their synapses, which are the junctions where they transmit signals to other neurons or effector cells such as muscles and glands. These fibers are a part of the cholinergic system, which plays crucial roles in various physiological processes including learning and memory, attention, arousal, sleep, and muscle contraction.

Cholinergic fibers can be found in both the central nervous system (CNS) and the peripheral nervous system (PNS). In the CNS, cholinergic neurons are primarily located in the basal forebrain and brainstem, and their projections innervate various regions of the cerebral cortex, hippocampus, thalamus, and other brain areas. In the PNS, cholinergic fibers are responsible for activating skeletal muscles through neuromuscular junctions, as well as regulating functions in smooth muscles, cardiac muscles, and glands via the autonomic nervous system.

Dysfunction of the cholinergic system has been implicated in several neurological disorders, such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis.

The Autonomic Nervous System (ANS) is a part of the peripheral nervous system that operates largely below the level of consciousness and controls visceral functions. It is divided into two main subdivisions: the sympathetic and parasympathetic nervous systems, which generally have opposing effects and maintain homeostasis in the body.

The Sympathetic Nervous System (SNS) prepares the body for stressful or emergency situations, often referred to as the "fight or flight" response. It increases heart rate, blood pressure, respiratory rate, and metabolic rate, while also decreasing digestive activity. This response helps the body respond quickly to perceived threats.

The Parasympathetic Nervous System (PNS), on the other hand, promotes the "rest and digest" state, allowing the body to conserve energy and restore itself after the stress response has subsided. It decreases heart rate, blood pressure, and respiratory rate, while increasing digestive activity and promoting relaxation.

These two systems work together to maintain balance in the body by adjusting various functions based on internal and external demands. Disorders of the Autonomic Nervous System can lead to a variety of symptoms, such as orthostatic hypotension, gastroparesis, and cardiac arrhythmias, among others.

Bethanechol compounds are a type of cholinergic agent used in medical treatment. They are parasympathomimetic drugs, which means they mimic the actions of the neurotransmitter acetylcholine at muscarinic receptors. Specifically, bethanechol compounds stimulate the muscarinic receptors in the smooth muscle of the bladder and gastrointestinal tract, increasing tone and promoting contractions.

Bethanechol is primarily used to treat urinary retention and associated symptoms, such as those that can occur after certain types of surgery or with conditions like spinal cord injury or multiple sclerosis. It works by helping the bladder muscle contract, which can promote urination.

It's important to note that bethanechol should be used with caution, as it can have various side effects, including sweating, increased salivation, flushed skin, and gastrointestinal symptoms like nausea, vomiting, or diarrhea. It may also interact with other medications, so it's crucial to discuss any potential risks with a healthcare provider before starting this treatment.

Bradycardia is a medical term that refers to an abnormally slow heart rate, typically defined as a resting heart rate of less than 60 beats per minute in adults. While some people, particularly well-trained athletes, may have a naturally low resting heart rate, bradycardia can also be a sign of an underlying health problem.

There are several potential causes of bradycardia, including:

* Damage to the heart's electrical conduction system, such as from heart disease or aging
* Certain medications, including beta blockers, calcium channel blockers, and digoxin
* Hypothyroidism (underactive thyroid gland)
* Sleep apnea
* Infection of the heart (endocarditis or myocarditis)
* Infiltrative diseases such as amyloidosis or sarcoidosis

Symptoms of bradycardia can vary depending on the severity and underlying cause. Some people with bradycardia may not experience any symptoms, while others may feel weak, fatigued, dizzy, or short of breath. In severe cases, bradycardia can lead to fainting, confusion, or even cardiac arrest.

Treatment for bradycardia depends on the underlying cause. If a medication is causing the slow heart rate, adjusting the dosage or switching to a different medication may help. In other cases, a pacemaker may be necessary to regulate the heart's rhythm. It is important to seek medical attention if you experience symptoms of bradycardia, as it can be a sign of a serious underlying condition.

Oxotremorine is a muscarinic receptor agonist, which means it binds to and activates muscarinic acetylcholine receptors. These receptors are found in the central and peripheral nervous system and are involved in various physiological functions, including cognition, motivation, reward, motor control, and sensory processing.

Oxotremorine is primarily used in research settings to study the role of muscarinic receptors in different physiological processes and diseases. It has been shown to produce effects similar to those caused by natural neurotransmitter acetylcholine, such as increased salivation, sweating, and gastrointestinal motility.

In addition, oxotremorine has been investigated for its potential therapeutic use in the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. However, its clinical use is limited due to its side effects, such as nausea, vomiting, diarrhea, and abdominal cramps.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

Salivation is the process of producing and secreting saliva by the salivary glands in the mouth. It is primarily a reflex response to various stimuli such as thinking about or tasting food, chewing, and speaking. Saliva plays a crucial role in digestion by moistening food and helping to create a food bolus that can be swallowed easily. Additionally, saliva contains enzymes like amylase which begin the process of digesting carbohydrates even before food enters the stomach. Excessive salivation is known as hypersalivation or ptyalism, while reduced salivation is called xerostomia.

Cholinergic receptors are a type of receptor in the body that are activated by the neurotransmitter acetylcholine. Acetylcholine is a chemical that nerve cells use to communicate with each other and with muscles. There are two main types of cholinergic receptors: muscarinic and nicotinic.

Muscarinic receptors are found in the heart, smooth muscle, glands, and the central nervous system. They are activated by muscarine, a type of alkaloid found in certain mushrooms. When muscarinic receptors are activated, they can cause changes in heart rate, blood pressure, and other bodily functions.

Nicotinic receptors are found in the nervous system and at the junction between nerves and muscles (the neuromuscular junction). They are activated by nicotine, a type of alkaloid found in tobacco plants. When nicotinic receptors are activated, they can cause the release of neurotransmitters and the contraction of muscles.

Cholinergic receptors play an important role in many physiological processes, including learning, memory, and movement. They are also targets for drugs used to treat a variety of medical conditions, such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis (a disorder that causes muscle weakness).

Preanesthetic medication, also known as premedication, refers to the administration of medications before anesthesia to help prepare the patient for the upcoming procedure. These medications can serve various purposes, such as:

1. Anxiolysis: Reducing anxiety and promoting relaxation in patients before surgery.
2. Amnesia: Causing temporary memory loss to help patients forget the events leading up to the surgery.
3. Analgesia: Providing pain relief to minimize discomfort during and after the procedure.
4. Antisialagogue: Decreasing saliva production to reduce the risk of aspiration during intubation.
5. Bronchodilation: Relaxing bronchial smooth muscles, which can help improve respiratory function in patients with obstructive lung diseases.
6. Antiemetic: Preventing or reducing the likelihood of postoperative nausea and vomiting.
7. Sedation: Inducing a state of calmness and drowsiness to facilitate a smooth induction of anesthesia.

Common preanesthetic medications include benzodiazepines (e.g., midazolam), opioids (e.g., fentanyl), anticholinergics (e.g., glycopyrrolate), and H1-antihistamines (e.g., diphenhydramine). The choice of preanesthetic medication depends on the patient's medical history, comorbidities, and the type of anesthesia to be administered.

Quinuclidinyl benzilate is a synthetic chemical compound that acts as a potent anticholinergic drug. Its chemical formula is C18H26N2O2. It is an odorless, white crystalline powder that is slightly soluble in water and more soluble in organic solvents.

Quinuclidinyl benzilate is a deliriant drug, which means it can cause delirium, confusion, hallucinations, and other altered mental states. It works by blocking the action of acetylcholine, a neurotransmitter in the brain that is involved in memory, attention, and perception.

This compound has been used in research as a tool to study the nervous system and has also been explored for its potential use as a chemical weapon. It is classified as a Schedule II controlled substance in the United States due to its high potential for abuse and the risk of severe psychological harm.

Cholinergic agonists are substances that bind to and activate cholinergic receptors, which are neuroreceptors that respond to the neurotransmitter acetylcholine. These agents can mimic the effects of acetylcholine in the body and are used in medical treatment to produce effects such as pupil constriction, increased gastrointestinal motility, bronchodilation, and improved cognition. Examples of cholinergic agonists include pilocarpine, bethanechol, and donepezil.

Scopolamine hydrobromide is a synthetic anticholinergic drug, which means it blocks the action of acetylcholine, a neurotransmitter in the nervous system. It is primarily used for its anti-motion sickness and anti-nausea effects. It can also be used to help with symptoms of Parkinson's disease, such as muscle stiffness and tremors.

In medical settings, scopolamine hydrobromide may be administered as a transdermal patch, which is placed behind the ear to allow for slow release into the body over several days. It can also be given as an injection or taken orally in the form of tablets or liquid solutions.

It's important to note that scopolamine hydrobromide can have various side effects, including dry mouth, blurred vision, dizziness, and drowsiness. It may also cause confusion, especially in older adults, and should be used with caution in patients with glaucoma, enlarged prostate, or certain heart conditions.

Cholinergic agents are a class of drugs that mimic the action of acetylcholine, a neurotransmitter in the body that is involved in the transmission of nerve impulses. These agents work by either increasing the amount of acetylcholine in the synapse (the space between two neurons) or enhancing its action on receptors.

Cholinergic agents can be classified into two main categories: direct-acting and indirect-acting. Direct-acting cholinergic agents, also known as parasympathomimetics, directly stimulate muscarinic and nicotinic acetylcholine receptors. Examples of direct-acting cholinergic agents include pilocarpine, bethanechol, and carbamate.

Indirect-acting cholinergic agents, on the other hand, work by inhibiting the enzyme acetylcholinesterase, which is responsible for breaking down acetylcholine in the synapse. By inhibiting this enzyme, indirect-acting cholinergic agents increase the amount of acetylcholine available to stimulate receptors. Examples of indirect-acting cholinergic agents include physostigmine, neostigmine, and edrophonium.

Cholinergic agents are used in the treatment of a variety of medical conditions, including myasthenia gravis, Alzheimer's disease, glaucoma, and gastrointestinal disorders. However, they can also have significant side effects, such as bradycardia, bronchoconstriction, and increased salivation, due to their stimulation of muscarinic receptors. Therefore, they must be used with caution and under the close supervision of a healthcare provider.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

Cholinergic antagonists, also known as anticholinergics or parasympatholytics, are a class of drugs that block the action of the neurotransmitter acetylcholine in the nervous system. They achieve this by binding to and blocking the activation of muscarinic acetylcholine receptors, which are found in various organs throughout the body, including the eyes, lungs, heart, gastrointestinal tract, and urinary bladder.

The blockade of these receptors results in a range of effects depending on the specific organ system involved. For example, cholinergic antagonists can cause mydriasis (dilation of the pupils), cycloplegia (paralysis of the ciliary muscle of the eye), tachycardia (rapid heart rate), reduced gastrointestinal motility and secretion, urinary retention, and respiratory tract smooth muscle relaxation.

Cholinergic antagonists are used in a variety of clinical settings, including the treatment of conditions such as Parkinson's disease, chronic obstructive pulmonary disease (COPD), asthma, gastrointestinal disorders, and urinary incontinence. Some common examples of cholinergic antagonists include atropine, scopolamine, ipratropium, and oxybutynin.

It's important to note that cholinergic antagonists can have significant side effects, particularly when used in high doses or in combination with other medications that affect the nervous system. These side effects can include confusion, memory impairment, hallucinations, delirium, and blurred vision. Therefore, it's essential to use these drugs under the close supervision of a healthcare provider and to follow their instructions carefully.

Ganglionic blockers are a type of medication that blocks the activity of the ganglia, which are clusters of nerve cells located outside the central nervous system. These medications work by blocking the transmission of nerve impulses between the ganglia and the effector organs they innervate, such as muscles or glands.

Ganglionic blockers were once used in the treatment of various conditions, including hypertension (high blood pressure), peptic ulcers, and certain types of pain. However, their use has largely been abandoned due to their significant side effects, which can include dry mouth, blurred vision, constipation, difficulty urinating, and dizziness or lightheadedness upon standing.

There are two main types of ganglionic blockers: nicotinic and muscarinic. Nicotinic ganglionic blockers block the action of acetylcholine at nicotinic receptors in the ganglia, while muscarinic ganglionic blockers block the action of acetylcholine at muscarinic receptors in the ganglia.

Examples of ganglionic blockers include trimethaphan, hexamethonium, and pentolinium. These medications are typically administered intravenously in a hospital setting due to their short duration of action and potential for serious side effects.

Muscarine is a naturally occurring organic compound that is classified as an alkaloid. It is found in various mushrooms, particularly those in the Amanita genus such as Amanita muscaria (the fly agaric) and Amanita pantherina. Muscarine acts as a parasympathomimetic, which means it can bind to and stimulate the same receptors as the neurotransmitter acetylcholine in the parasympathetic nervous system. This can lead to various effects on the body, including slowed heart rate, increased salivation, constricted pupils, and difficulty breathing. In high doses, muscarine can be toxic and even life-threatening.

Dichlorvos is a type of organophosphate insecticide that is used to control a wide variety of pests in agricultural, residential, and industrial settings. Its chemical formula is (2,2-dichlorovinyl) dimethyl phosphate. It works by inhibiting the enzyme acetylcholinesterase, which leads to an accumulation of the neurotransmitter acetylcholine in the synaptic clefts of nerve cells, causing overstimulation of the nervous system and ultimately death of the pest.

Dichlorvos is highly toxic to both insects and mammals, including humans. Exposure to this chemical can cause a range of symptoms, including headache, dizziness, nausea, vomiting, muscle weakness, and in severe cases, respiratory failure and death. It is classified as a Category I acute toxicant by the Environmental Protection Agency (EPA) and is listed as a hazardous substance under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).

Due to its high toxicity and potential for environmental persistence, dichlorvos is subject to strict regulations in many countries. It is banned or restricted for use in several jurisdictions, including the European Union, Canada, and some states in the United States. Where it is still allowed, it is typically used only under specific conditions and with appropriate safety measures in place.

Tropane alkaloids are a class of naturally occurring compounds that contain a tropane ring in their chemical structure. This ring is composed of a seven-membered ring with two nitrogen atoms, one of which is part of a piperidine ring. Tropane alkaloids are found in various plants, particularly those in the Solanaceae family, which includes nightshade, belladonna, and datura. Some well-known tropane alkaloids include atropine, scopolamine, and cocaine. These compounds have diverse pharmacological activities, such as anticholinergic, local anesthetic, and central nervous system stimulant effects.

Sympatholytics are a class of drugs that block the action of the sympathetic nervous system, which is the part of the autonomic nervous system responsible for preparing the body for the "fight or flight" response. Sympatholytics achieve this effect by binding to and blocking alpha-adrenergic receptors or beta-adrenergic receptors located in various organs throughout the body, including the heart, blood vessels, lungs, gastrointestinal tract, and urinary system.

Examples of sympatholytic drugs include:

* Alpha blockers (e.g., prazosin, doxazosin)
* Beta blockers (e.g., propranolol, metoprolol)
* Centrally acting sympatholytics (e.g., clonidine, methyldopa)

Sympatholytics are used to treat a variety of medical conditions, including hypertension, angina, heart failure, arrhythmias, and certain neurological disorders. They may also be used to manage symptoms associated with anxiety or withdrawal from alcohol or other substances.

Histamine is defined as a biogenic amine that is widely distributed throughout the body and is involved in various physiological functions. It is derived primarily from the amino acid histidine by the action of histidine decarboxylase. Histamine is stored in granules (along with heparin and proteases) within mast cells and basophils, and is released upon stimulation or degranulation of these cells.

Once released into the tissues and circulation, histamine exerts a wide range of pharmacological actions through its interaction with four types of G protein-coupled receptors (H1, H2, H3, and H4 receptors). Histamine's effects are diverse and include modulation of immune responses, contraction and relaxation of smooth muscle, increased vascular permeability, stimulation of gastric acid secretion, and regulation of neurotransmission.

Histamine is also a potent mediator of allergic reactions and inflammation, causing symptoms such as itching, sneezing, runny nose, and wheezing. Antihistamines are commonly used to block the actions of histamine at H1 receptors, providing relief from these symptoms.

In anatomical terms, the stomach is a muscular, J-shaped organ located in the upper left portion of the abdomen. It is part of the gastrointestinal tract and plays a crucial role in digestion. The stomach's primary functions include storing food, mixing it with digestive enzymes and hydrochloric acid to break down proteins, and slowly emptying the partially digested food into the small intestine for further absorption of nutrients.

The stomach is divided into several regions, including the cardia (the area nearest the esophagus), the fundus (the upper portion on the left side), the body (the main central part), and the pylorus (the narrowed region leading to the small intestine). The inner lining of the stomach, called the mucosa, is protected by a layer of mucus that prevents the digestive juices from damaging the stomach tissue itself.

In medical contexts, various conditions can affect the stomach, such as gastritis (inflammation of the stomach lining), peptic ulcers (sores in the stomach or duodenum), gastroesophageal reflux disease (GERD), and stomach cancer. Symptoms related to the stomach may include abdominal pain, bloating, nausea, vomiting, heartburn, and difficulty swallowing.

"Cat" is a common name that refers to various species of small carnivorous mammals that belong to the family Felidae. The domestic cat, also known as Felis catus or Felis silvestris catus, is a popular pet and companion animal. It is a subspecies of the wildcat, which is found in Europe, Africa, and Asia.

Domestic cats are often kept as pets because of their companionship, playful behavior, and ability to hunt vermin. They are also valued for their ability to provide emotional support and therapy to people. Cats are obligate carnivores, which means that they require a diet that consists mainly of meat to meet their nutritional needs.

Cats are known for their agility, sharp senses, and predatory instincts. They have retractable claws, which they use for hunting and self-defense. Cats also have a keen sense of smell, hearing, and vision, which allow them to detect prey and navigate their environment.

In medical terms, cats can be hosts to various parasites and diseases that can affect humans and other animals. Some common feline diseases include rabies, feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), and toxoplasmosis. It is important for cat owners to keep their pets healthy and up-to-date on vaccinations and preventative treatments to protect both the cats and their human companions.

Pentolinium tartrate is a synthetic anticholinergic drug, which is primarily used as a peripheral nerve blocker in surgical procedures. It functions by blocking the action of acetylcholine, a neurotransmitter that stimulates involuntary muscle contractions, secretions, and other physiological responses.

The tartrate form of pentolinium is a salt of pentolinium, which increases its solubility in water and facilitates its administration as an injection. The drug works by blocking the muscarinic acetylcholine receptors, particularly those found in smooth muscle, glands, and the heart.

Pentolinium tartrate is used to reduce salivation, sweating, and other autonomic responses during surgical procedures. It may also be used to treat conditions such as hypertension or urinary incontinence, although its use for these indications has declined with the development of newer drugs.

As with any medication, pentolinium tartrate can have side effects, including dry mouth, blurred vision, dizziness, and constipation. It should be used with caution in patients with certain medical conditions, such as glaucoma or prostatic hypertrophy, and should not be used in patients with a history of allergic reactions to the drug.

Muscle relaxation, in a medical context, refers to the process of reducing tension and promoting relaxation in the skeletal muscles. This can be achieved through various techniques, including progressive muscle relaxation (PMR), where individuals consciously tense and then release specific muscle groups in a systematic manner.

PMR has been shown to help reduce anxiety, stress, and muscle tightness, and improve overall well-being. It is often used as a complementary therapy in conjunction with other treatments for conditions such as chronic pain, headaches, and insomnia.

Additionally, muscle relaxation can also be facilitated through pharmacological interventions, such as the use of muscle relaxant medications. These drugs work by inhibiting the transmission of signals between nerves and muscles, leading to a reduction in muscle tone and spasticity. They are commonly used to treat conditions such as multiple sclerosis, cerebral palsy, and spinal cord injuries.

Soman is a chemical compound with the formula (CH3)2(C=O)N(CH2)4SH. It is a potent nerve agent, a type of organic compound that can cause death by interfering with the nervous system's ability to regulate muscle movement. Soman is an odorless, colorless liquid that evaporates slowly at room temperature and is therefore classified as a "v-type" or "volatile" nerve agent. It is considered to be one of the most toxic substances known. Exposure to soman can occur through inhalation, skin contact, or ingestion, and it can cause a range of symptoms including nausea, seizures, respiratory failure, and death.

Bretylium compounds are a class of medications that are primarily used in the management of life-threatening cardiac arrhythmias (abnormal heart rhythms). Bretylium tosylate is the most commonly used formulation. It works by stabilizing the membranes of certain types of heart cells, which can help to prevent or stop ventricular fibrillation and other dangerous arrhythmias.

Bretylium compounds are typically administered intravenously in a hospital setting under close medical supervision. They may be used in conjunction with other medications and treatments for the management of cardiac emergencies. It's important to note that bretylium compounds have a narrow therapeutic index, which means that the difference between an effective dose and a toxic one is relatively small. Therefore, they should only be administered by healthcare professionals who are experienced in their use.

Like all medications, bretylium compounds can cause side effects, including but not limited to:
- Increased heart rate
- Low blood pressure
- Nausea and vomiting
- Dizziness or lightheadedness
- Headache
- Tremors or muscle twitching
- Changes in mental status or behavior

Healthcare providers will monitor patients closely for any signs of adverse reactions while they are receiving bretylium compounds.

Mecamylamine is a non-competitive antagonist at nicotinic acetylcholine receptors. It is primarily used in the treatment of hypertension (high blood pressure) that is resistant to other medications, although it has been largely replaced by newer drugs with fewer side effects.

Mecamylamine works by blocking the action of acetylcholine, a neurotransmitter that activates nicotinic receptors and plays a role in regulating blood pressure. By blocking these receptors, mecamylamine can help to reduce blood vessel constriction and lower blood pressure.

It is important to note that mecamylamine can have significant side effects, including dry mouth, dizziness, blurred vision, constipation, and difficulty urinating. It may also cause orthostatic hypotension (a sudden drop in blood pressure when standing up), which can increase the risk of falls and fractures in older adults. As a result, mecamylamine is typically used as a last resort in patients with severe hypertension who have not responded to other treatments.

I couldn't find a medical definition for "Depression, Chemical" as it is not a recognized medical term. However, I can provide you with information about chemical imbalances in the brain that are associated with depression.

Major depressive disorder (MDD), commonly referred to as depression, is believed to be caused by a combination of genetic, environmental, and physiological factors. While there is no definitive evidence that depression is solely caused by a "chemical imbalance," neurotransmitter irregularities in the brain are associated with depressive symptoms. Neurotransmitters are chemical messengers that transmit signals in the brain and other parts of the body. Some of the primary neurotransmitters involved in mood regulation include serotonin, norepinephrine, and dopamine.

In depression, it is thought that there may be alterations in the functioning of these neurotransmitter systems, leading to an imbalance. For example:

1. Serotonin: Low levels of serotonin are associated with depressive symptoms. Selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressants, work by increasing the availability of serotonin in the synapse (the space between neurons) to improve communication between brain cells.
2. Norepinephrine: Imbalances in norepinephrine levels can contribute to depressive symptoms and anxiety. Norepinephrine reuptake inhibitors (NRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs) are medications that target norepinephrine to help alleviate depression.
3. Dopamine: Deficiencies in dopamine can lead to depressive symptoms, anhedonia (the inability to feel pleasure), and motivation loss. Some antidepressants, like bupropion, work by increasing dopamine levels in the brain.

In summary, while "Chemical Depression" is not a recognized medical term, chemical imbalances in neurotransmitter systems are associated with depressive symptoms. However, depression is a complex disorder that cannot be solely attributed to a single cause or a simple chemical imbalance. It is essential to consider multiple factors when diagnosing and treating depression.

The urinary bladder is a muscular, hollow organ in the pelvis that stores urine before it is released from the body. It expands as it fills with urine and contracts when emptying. The typical adult bladder can hold between 400 to 600 milliliters of urine for about 2-5 hours before the urge to urinate occurs. The wall of the bladder contains several layers, including a mucous membrane, a layer of smooth muscle (detrusor muscle), and an outer fibrous adventitia. The muscles of the bladder neck and urethra remain contracted to prevent leakage of urine during filling, and they relax during voiding to allow the urine to flow out through the urethra.

The trachea, also known as the windpipe, is a tube-like structure in the respiratory system that connects the larynx (voice box) to the bronchi (the two branches leading to each lung). It is composed of several incomplete rings of cartilage and smooth muscle, which provide support and flexibility. The trachea plays a crucial role in directing incoming air to the lungs during inspiration and outgoing air to the larynx during expiration.

A muscarinic M3 receptor is a type of G protein-coupled receptor (GPCR) that binds to the neurotransmitter acetylcholine. It is a subtype of muscarinic receptors, which are named after the muscarine mushroom alkaloid that can activate them.

The M3 receptor is widely expressed in various tissues and organs, including the smooth muscle of the gastrointestinal tract, urinary bladder, respiratory system, and vasculature. When activated by acetylcholine or muscarinic agonists, it triggers a range of intracellular signaling pathways that lead to various physiological responses, such as smooth muscle contraction, glandular secretion, and modulation of neurotransmitter release.

The M3 receptor is known to couple primarily to the Gq/11 family of G proteins, which activate phospholipase C (PLC) and increase intracellular calcium levels. This leads to smooth muscle contraction and other downstream effects. The M3 receptor also interacts with other signaling pathways, such as those involving adenylyl cyclase, mitogen-activated protein kinases (MAPKs), and ion channels.

Dysregulation of muscarinic M3 receptors has been implicated in various diseases, including gastrointestinal disorders, overactive bladder syndrome, asthma, and cardiovascular diseases. Therefore, selective modulation of this receptor subtype is a potential therapeutic strategy for these conditions.

Norepinephrine, also known as noradrenaline, is a neurotransmitter and a hormone that is primarily produced in the adrenal glands and is released into the bloodstream in response to stress or physical activity. It plays a crucial role in the "fight-or-flight" response by preparing the body for action through increasing heart rate, blood pressure, respiratory rate, and glucose availability.

As a neurotransmitter, norepinephrine is involved in regulating various functions of the nervous system, including attention, perception, motivation, and arousal. It also plays a role in modulating pain perception and responding to stressful or emotional situations.

In medical settings, norepinephrine is used as a vasopressor medication to treat hypotension (low blood pressure) that can occur during septic shock, anesthesia, or other critical illnesses. It works by constricting blood vessels and increasing heart rate, which helps to improve blood pressure and perfusion of vital organs.

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid polypeptide hormone that has potent vasodilatory, secretory, and neurotransmitter effects. It is widely distributed throughout the body, including in the gastrointestinal tract, where it is synthesized and released by nerve cells (neurons) in the intestinal mucosa. VIP plays a crucial role in regulating various physiological functions such as intestinal secretion, motility, and blood flow. It also has immunomodulatory effects and may play a role in neuroprotection. High levels of VIP are found in the brain, where it acts as a neurotransmitter or neuromodulator and is involved in various cognitive functions such as learning, memory, and social behavior.

Methysergide is a medication that belongs to a class of drugs called ergot alkaloids. It is primarily used for the prophylaxis (prevention) of migraine headaches. Methysergide works by narrowing blood vessels around the brain, which is thought to help prevent migraines.

The medical definition of Methysergide is:
A semisynthetic ergot alkaloid derivative used in the prophylaxis of migraine and cluster headaches. It has both agonist and antagonist properties at serotonin receptors, and its therapeutic effects are thought to be related to its ability to block the binding of serotonin to its receptors. However, methysergide can have serious side effects, including fibrotic reactions in various organs, such as the heart, lungs, and kidneys, so it is usually used only for short periods of time and under close medical supervision.

Gastric juice is a digestive fluid that is produced in the stomach. It is composed of several enzymes, including pepsin, which helps to break down proteins, and gastric amylase, which begins the digestion of carbohydrates. Gastric juice also contains hydrochloric acid, which creates a low pH environment in the stomach that is necessary for the activation of pepsin and the digestion of food. Additionally, gastric juice contains mucus, which helps to protect the lining of the stomach from the damaging effects of the hydrochloric acid. The production of gastric juice is controlled by hormones and the autonomic nervous system.

Secretory rate refers to the amount or volume of a secretion produced by a gland or an organ over a given period of time. It is a measure of the productivity or activity level of the secreting structure. The secretory rate can be quantified for various bodily fluids, such as saliva, sweat, digestive enzymes, hormones, or milk, depending on the context and the specific gland or organ being studied.

In clinical settings, measuring the secretory rate might involve collecting and analyzing samples over a certain duration to estimate the production rate of the substance in question. This information can be helpful in diagnosing conditions related to impaired secretion, monitoring treatment responses, or understanding the physiological adaptations of the body under different circumstances.

Metiamide is not generally considered a medical term, but it is a medication that has been used in the past. Medically, metiamide is defined as a synthetic histamine H2-receptor antagonist, which means it blocks the action of histamine at the H2 receptors in the stomach. This effect reduces gastric acid secretion and can be useful in treating gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions associated with excessive stomach acid production.

However, metiamide has largely been replaced by other H2 blockers like cimetidine, ranitidine, and famotidine due to its association with a rare but serious side effect called agranulocytosis, which is a severe decrease in white blood cell count that can increase the risk of infections.

Dimethylphenylpiperazinium iodide is not a medical term or a medication commonly used in clinical practice. It's a chemical compound with the formula (C12H18N2)I, where dimethylphenylpiperazinium is the cation and iodide is the anion.

The dimethylphenylpiperazinium portion of the molecule consists of a phenyl ring with two methyl groups attached to it and a piperazine ring, which contains two nitrogen atoms. This compound may be used in research settings for various purposes, including as a reagent or an intermediate in chemical synthesis.

As this compound is not a medication, there is no medical definition associated with it. If you have any questions about its use or potential applications, please consult a relevant professional such as a chemist or pharmacologist.

Ophthalmic solutions are sterile, single-use or multi-dose preparations in a liquid form that are intended for topical administration to the eye. These solutions can contain various types of medications, such as antibiotics, anti-inflammatory agents, antihistamines, or lubricants, which are used to treat or prevent ocular diseases and conditions.

The pH and osmolarity of ophthalmic solutions are carefully controlled to match the physiological environment of the eye and minimize any potential discomfort or irritation. The solutions may be packaged in various forms, including drops, sprays, or irrigations, depending on the intended use and administration route.

It is important to follow the instructions for use provided by a healthcare professional when administering ophthalmic solutions, as improper use can lead to eye injury or reduced effectiveness of the medication.

Substance P is an undecapeptide neurotransmitter and neuromodulator, belonging to the tachykinin family of peptides. It is widely distributed in the central and peripheral nervous systems and is primarily found in sensory neurons. Substance P plays a crucial role in pain transmission, inflammation, and various autonomic functions. It exerts its effects by binding to neurokinin 1 (NK-1) receptors, which are expressed on the surface of target cells. Apart from nociception and inflammation, Substance P is also involved in regulating emotional behaviors, smooth muscle contraction, and fluid balance.

A reflex is an automatic, involuntary and rapid response to a stimulus that occurs without conscious intention. In the context of physiology and neurology, it's a basic mechanism that involves the transmission of nerve impulses between neurons, resulting in a muscle contraction or glandular secretion.

Reflexes are important for maintaining homeostasis, protecting the body from harm, and coordinating movements. They can be tested clinically to assess the integrity of the nervous system, such as the knee-j jerk reflex, which tests the function of the L3-L4 spinal nerve roots and the sensitivity of the stretch reflex arc.

Phenoxybenzamine is an antihypertensive medication that belongs to a class of drugs known as non-selective alpha blockers. It works by blocking both alpha-1 and alpha-2 receptors, which results in the relaxation of smooth muscle tissue in blood vessel walls and other organs. This leads to a decrease in peripheral vascular resistance and a reduction in blood pressure.

Phenoxybenzamine is primarily used for the preoperative management of patients with pheochromocytoma, a rare tumor that produces excessive amounts of catecholamines, such as adrenaline and noradrenaline. By blocking alpha receptors, phenoxybenzamine prevents the hypertensive crisis that can occur during surgery to remove the tumor.

It's important to note that phenoxybenzamine has a long duration of action (up to 14 days) and can cause orthostatic hypotension, tachycardia, and other side effects. Therefore, it should be used with caution and under the close supervision of a healthcare professional.

A muscarinic M2 receptor is a type of G protein-coupled receptor (GPCR) that binds to the neurotransmitter acetylcholine. It is one of five subtypes of muscarinic receptors (M1-M5) and is widely distributed throughout the body, particularly in the heart, smooth muscle, and exocrine glands.

The M2 receptor is coupled to the G protein inhibitory Gαi/o, which inhibits adenylyl cyclase activity and reduces intracellular cAMP levels. This leads to a variety of physiological responses, including negative chronotropy (slowing of heart rate) and negative inotropy (decreased contractility) in the heart, relaxation of smooth muscle in the bronchioles and gastrointestinal tract, and inhibition of exocrine gland secretion.

The M2 receptor is an important target for drugs used to treat a variety of conditions, including cardiovascular diseases, asthma, chronic obstructive pulmonary disease (COPD), and gastrointestinal disorders. Anticholinergic drugs such as atropine and ipratropium bind to the M2 receptor and block its activity, while muscarinic agonists such as bethanechol activate the receptor.

Sympathomimetic drugs are substances that mimic or stimulate the actions of the sympathetic nervous system. The sympathetic nervous system is one of the two divisions of the autonomic nervous system, which regulates various automatic physiological functions in the body. The sympathetic nervous system's primary function is to prepare the body for the "fight-or-flight" response, which includes increasing heart rate, blood pressure, respiratory rate, and metabolism while decreasing digestive activity.

Sympathomimetic drugs can exert their effects through various mechanisms, including directly stimulating adrenergic receptors (alpha and beta receptors) or indirectly causing the release of norepinephrine and epinephrine from nerve endings. These drugs are used in various clinical settings to treat conditions such as asthma, nasal congestion, low blood pressure, and attention deficit hyperactivity disorder (ADHD). Examples of sympathomimetic drugs include epinephrine, norepinephrine, dopamine, dobutamine, albuterol, pseudoephedrine, and methylphenidate.

It is important to note that sympathomimetic drugs can also have adverse effects, particularly when used in high doses or in individuals with certain medical conditions. These adverse effects may include anxiety, tremors, palpitations, hypertension, arrhythmias, and seizures. Therefore, these medications should be used under the close supervision of a healthcare provider.

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

Pilocarpine is a cholinergic agonist, which means it stimulates the parasympathetic nervous system by binding to muscarinic receptors. It is primarily used in the treatment of dry mouth (xerostomia) caused by radiation therapy or Sjögren's syndrome, as well as in the management of glaucoma due to its ability to construct the pupils and reduce intraocular pressure. Pilocarpine can also be used to treat certain cardiovascular conditions and chronic bronchitis. It is available in various forms, including tablets, ophthalmic solutions, and topical gels.

The gastric fundus is the upper, rounded portion of the stomach that lies above the level of the cardiac orifice and extends up to the left dome-shaped part of the diaphragm. It is the part of the stomach where food and liquids are first stored after entering through the esophagus. The gastric fundus contains parietal cells, which secrete hydrochloric acid, and chief cells, which produce pepsinogen, a precursor to the digestive enzyme pepsin. It is also the site where the hormone ghrelin is produced, which stimulates appetite.

N-Methylscopolamine is a anticholinergic drug, which means it blocks the action of acetylcholine, a neurotransmitter in the body. It is a derivative of scopolamine and is used to treat various conditions such as gastrointestinal disorders (such as gastritis, peptic ulcer), Parkinson's disease, motion sickness, and to reduce saliva production during surgical or diagnostic procedures.

It works by blocking the muscarinic receptors in the nervous system, which leads to a decrease in the secretion of fluids (such as saliva, sweat, stomach acid) and decreased muscle contractions in the gastrointestinal tract. N-Methylscopolamine can also cause side effects such as dizziness, dry mouth, blurred vision, and difficulty urinating.

Tachykinins are a group of neuropeptides that share a common carboxy-terminal sequence and bind to G protein-coupled receptors, called tachykinin receptors. They are widely distributed in the nervous system and play important roles as neurotransmitters or neuromodulators in various physiological functions, such as pain transmission, smooth muscle contraction, and inflammation. The most well-known tachykinins include substance P, neurokinin A, and neuropeptide K. They are involved in many pathological conditions, including chronic pain, neuroinflammation, and neurodegenerative diseases.

Metipranolol is a non-selective beta blocker, which is a type of medication that works by blocking the effects of certain hormones like adrenaline (epinephrine) on the heart and blood vessels. This results in a slower heart rate, decreased force of heart contractions, and reduced blood vessel contraction, leading to lower blood pressure and improved oxygen supply to the heart.

Metipranolol is primarily used to treat open-angle glaucoma and ocular hypertension by reducing the production of fluid within the eye, thereby decreasing intraocular pressure. It is available as an ophthalmic solution for topical application.

It's important to note that systemic absorption of metipranolol can occur after ophthalmic use, and it may cause systemic side effects such as bradycardia (slow heart rate), hypotension (low blood pressure), and bronchospasm (narrowing of the airways) in some individuals. Therefore, patients should be monitored for potential systemic side effects during treatment with metipranolol.

An adjuvant in anesthesia refers to a substance or drug that is added to an anesthetic medication to enhance its effects, make it last longer, or improve the overall quality of anesthesia. Adjuvants do not produce analgesia or anesthesia on their own but work synergistically with other anesthetics to achieve better clinical outcomes.

There are several types of adjuvants used in anesthesia, including:

1. Opioids: These are commonly used adjuvants that enhance the analgesic effect of anesthetic drugs. Examples include fentanyl, sufentanil, and remifentanil.
2. Alpha-2 agonists: Drugs like clonidine and dexmedetomidine are used as adjuvants to provide sedation, analgesia, and anxiolysis. They also help reduce the requirement for other anesthetic drugs, thus minimizing side effects.
3. Ketamine: This NMDA receptor antagonist is used as an adjuvant to provide analgesia and amnesia. It can be used in subanesthetic doses to improve the quality of analgesia during general anesthesia or as a sole anesthetic for procedural sedation.
4. Local anesthetics: When used as an adjuvant, local anesthetics can prolong the duration of postoperative analgesia and reduce the requirement for opioids. Examples include bupivacaine, ropivacaine, and lidocaine.
5. Neostigmine: This cholinesterase inhibitor is used as an adjuvant to reverse the neuromuscular blockade produced by non-depolarizing muscle relaxants at the end of surgery.
6. Dexamethasone: A corticosteroid used as an adjuvant to reduce postoperative nausea and vomiting, inflammation, and pain.
7. Magnesium sulfate: This non-competitive NMDA receptor antagonist is used as an adjuvant to provide analgesia, reduce opioid consumption, and provide neuroprotection in certain surgical settings.

The choice of adjuvants depends on the type of surgery, patient factors, and the desired clinical effects.

A muscarinic acetylcholine receptor (mAChR) is a type of G protein-coupled receptor (GPCR) that binds the neurotransmitter acetylcholine and mediates various responses in the body. The M1 subtype of muscarinic receptors (CHRM1) is widely distributed throughout the central and peripheral nervous system, with particularly high densities found in the cerebral cortex, hippocampus, striatum, and autonomic ganglia.

Muscarinic M1 receptors are coupled to G proteins of the Gq/11 family, which activate phospholipase C (PLC) upon receptor activation. This leads to the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG), which further trigger intracellular signaling cascades.

The activation of muscarinic M1 receptors is involved in several physiological processes, including:

* Cognitive functions such as learning, memory, and attention
* Excitatory neurotransmission in the hippocampus
* Regulation of smooth muscle tone, particularly in the gastrointestinal tract and airways
* Secretion of various hormones and enzymes, including those involved in insulin release and lipid metabolism

Dysregulation of muscarinic M1 receptors has been implicated in several pathological conditions, such as Alzheimer's disease, Parkinson's disease, schizophrenia, and irritable bowel syndrome. Therefore, targeting these receptors with pharmacological agents presents a potential therapeutic strategy for treating these disorders.

The sympathetic nervous system (SNS) is a part of the autonomic nervous system that operates largely below the level of consciousness, and it functions to produce appropriate physiological responses to perceived danger. It's often associated with the "fight or flight" response. The SNS uses nerve impulses to stimulate target organs, causing them to speed up (e.g., increased heart rate), prepare for action, or otherwise respond to stressful situations.

The sympathetic nervous system is activated due to stressful emotional or physical situations and it prepares the body for immediate actions. It dilates the pupils, increases heart rate and blood pressure, accelerates breathing, and slows down digestion. The primary neurotransmitter involved in this system is norepinephrine (also known as noradrenaline).

The splanchnic nerves are a set of nerve fibers that originate from the thoracic and lumbar regions of the spinal cord and innervate various internal organs. They are responsible for carrying both sensory information, such as pain and temperature, from the organs to the brain, and motor signals, which control the function of the organs, from the brain to the organs.

There are several splanchnic nerves, including the greater, lesser, and least splanchnic nerves, as well as the lumbar splanchnic nerves. These nerves primarily innervate the autonomic nervous system, which controls the involuntary functions of the body, such as heart rate, digestion, and respiration.

The greater splanchnic nerve arises from the fifth to the ninth thoracic ganglia and passes through the diaphragm to reach the abdomen. It innervates the stomach, esophagus, liver, pancreas, and adrenal glands.

The lesser splanchnic nerve arises from the tenth and eleventh thoracic ganglia and innervates the upper part of the small intestine, the pancreas, and the adrenal glands.

The least splanchnic nerve arises from the twelfth thoracic ganglion and innervates the lower part of the small intestine and the colon.

The lumbar splanchnic nerves arise from the first three or four lumbar ganglia and innervate the lower parts of the colon, the rectum, and the reproductive organs.

Solanaceous alkaloids are a type of natural toxin found in plants belonging to the Solanaceae family, also known as the nightshade family. These alkaloids contain nitrogen and are produced by the plant as a defense mechanism against herbivores and other threats. Some common solanaceous alkaloids include nicotine, atropine, scopolamine, and solanine.

Nicotine is found in tobacco plants (Nicotiana tabacum) and is highly addictive. Atropine and scopolamine are found in belladonna (Atropa belladonna), also known as deadly nightshade, and are used in medical settings for their anticholinergic effects, but can be toxic or even fatal if ingested in large quantities. Solanine is found in potatoes, tomatoes, and eggplants, and can cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea if consumed in large amounts.

It's worth noting that the levels of solanaceous alkaloids in commonly consumed plants like potatoes and tomatoes are generally low and not considered harmful to most people. However, some individuals may be more sensitive to these compounds and may experience adverse effects even at low levels.

I could not find a medical definition for "Benzilates" as it is not a recognized term in medicine or pharmacology. It seems that you may have made a typographical error, and the correct term you are looking for might be "benzoylates." Benzoylates refer to salts or esters of benzoic acid, which have various uses including as preservatives and pharmaceutical ingredients.

If you meant something else by "Benzilates," please provide more context so I can give a more accurate response.

The parotid gland is the largest of the major salivary glands. It is a bilobed, accessory digestive organ that secretes serous saliva into the mouth via the parotid duct (Stensen's duct), located near the upper second molar tooth. The parotid gland is primarily responsible for moistening and lubricating food to aid in swallowing and digestion.

Anatomically, the parotid gland is located in the preauricular region, extending from the zygomatic arch superiorly to the angle of the mandible inferiorly, and from the masseter muscle anteriorly to the sternocleidomastoid muscle posteriorly. It is enclosed within a fascial capsule and has a rich blood supply from the external carotid artery and a complex innervation pattern involving both parasympathetic and sympathetic fibers.

Parotid gland disorders can include salivary gland stones (sialolithiasis), infections, inflammatory conditions, benign or malignant tumors, and autoimmune diseases such as Sjögren's syndrome.

Dicyclomine is an anticholinergic medication that is primarily used to treat gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS). It works by blocking the action of acetylcholine, a neurotransmitter that stimulates muscle contraction and other functions in the body.

In the GI tract, dicyclomine helps to reduce spasms and relax the muscles, which can alleviate symptoms such as abdominal cramping, bloating, and diarrhea. It is important to note that dicyclomine may have side effects, including dry mouth, blurred vision, dizziness, and constipation.

Additionally, it should be used with caution in older adults, people with certain medical conditions (such as glaucoma or enlarged prostate), and those taking other medications that can interact with dicyclomine. Always consult with a healthcare provider for proper dosage and usage instructions.

Injections of atropine are used in the treatment of symptomatic or unstable bradycardia. Atropine was previously included in ... Atropine or diphenhydramine can be used to treat muscarine intoxication.[medical citation needed] Atropine has been observed to ... atropine is poisonous.[medical citation needed] Atropine is sometimes added to potentially addictive drugs, particularly ... Even though atropine has not been officially indicated for either of these purposes by the FDA, it has been used by physicians ...
Atropine is the third album released by the black metal band Velvet Cacoon. It features a completely dark ambient sound. CD ...
"Atropine". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-08-08. Richards, John R.; Garber, Dariush; Laurin, Erik G.; Albertson, ... out by the ingestion and processing of drugs such as cocaine or atropine. This section discusses target heart rates for healthy ...
"Atropine". The American Society of Health-System Pharmacists. Archived from the original on 2015-07-12. Retrieved Aug 13, 2015 ...
In the 1850s, atropine was used as antispasmodic in asthma treatment and as morphine antidote for its mydriatic effect. Bezold ... Combined use with atropine increases the risk of severe hypertension. Alzheimer's disease e.g. rivastigmine and donepezil. May ... Atropine decreases the absorption of levodopa. Preventing travel sickness, relieve stomach cramps or spasms, e.g. hyoscine. ... Shutt LE, Bowes JB (May 1979). "Atropine and hyoscine". Anaesthesia. 34 (5): 476-90. doi:10.1111/j.1365-2044.1979.tb06327.x. ...
Geiger; Hesse (1833). "Fortgesetzte Versuche über Atropin" [Continued experiments on atropine]. Annalen der Pharmacie (in ... The effects of atropine on the central nervous system include memory disruption, which may lead to severe confusion. The major ... "Atropine Eye Drops". Archived from the original on 8 July 2008. Retrieved 2008-07-08. Wood, George Bacon (1867). A Treatise on ... 3.6, "History of Atropine as a poison". Robert S. Holzman, MD (July 1998). "The Legacy of Atropos". Anesthesiology. 89 (1): 241 ...
Varghese, S.; Vettath, N.; Iyer, K.; Puliyel, J. M.; Puliyel, M. M. (1990). "Ocular atropine induced psychosis--is there a ... Bergman, K. R.; Pearson, C.; Waltz, G. W.; Evans R. III (1980). "Atropine-induced psychosis. An unusual complication of therapy ... Prednisone and other corticosteroids Isotretinoin Anticholinergic drugs atropine scopolamine antidepressants L-dopa ... with inhaled atropine sulfate". Chest. 78 (6): 891-893. doi:10.1378/chest.78.6.891. PMID 7449475. ...
It is mainly known for the other alkaloids derived from it, which include atropine and cocaine, among others. Tropane alkaloids ... "Atropine content of plants". USDA, ARS, National Genetic Resources Program. Phytochemical and Ethnobotanical Databases. [Online ...
The antidote is atropine. T-1123 is a quaternary ammonium ion. A phenyl carbamate ester is bonded in the meta position to the ...
Atropine is an alkaloid first found in Atropa belladonna, a member of the nightshade family. While atropine was first isolated ... Overdosing of atropine may lead to atropine poisoning which results in side effects such as blurred vision, nausea, lack of ... "Atropine Side Effects Center". "Resveratrol: MedlinePlus Supplements". medlineplus.gov. Retrieved 2020-04-07. Vang O, Ahmad N, ... Currently atropine is administered intravenously to treat bradycardia and as an antidote to organophosphate poisoning. ...
Active ingredients are listed as: phenobarbital (16.2 mg), hyoscyamine sulfate (0.1037 mg), atropine sulfate (0.0194 mg), and ... compared Donnatal® tablets (hyoscyamine sulfate - 0.1037 mg; atropine sulfate - 0.0194 mg; scopolamine hydrobromide - 0.0065 mg ... and phenobarbital - 16.2 mg) to belladonna alkaloids alone (hyoscyamine sulfate - 0.1037 mg; atropine sulfate - 0.0194 mg; ...
An emergency antidote is atropine. Diazinon was developed in 1952 by the Swiss company Ciba-Geigy (now Novartis) to replace the ... Geller, Robert J.; Lopez, Gaylord P.; Cutler, Stephen; Lin, Diana; Bachman, George F.; Gorman, Susan E. (2003). "Atropine ... including the antidotes atropine and oxime. Gastric Lavage[citation needed] Patients that continue to improve over the first 4 ... availability as an antidote for nerve agent casualties: Validated rapid reformulation of high-concentration atropine from bulk ...
The specific antidote is atropine. Inducing vomiting to remove mushroom contents is also prudent due to the speed of onset of ...
"Atnaa Atropine And Pralidoxime Chloride Auto-Injector- atropine and pralidoxime chloride kit". DailyMed. 22 March 2017. ... The ATNAA provides atropine and pralidoxime chloride in a single delivery system, although the two drugs are separate within ... "Duodote- atropine and pralidoxime chloride kit". DailyMed. 22 October 2018. Retrieved 27 May 2020. FDA approval process "ATNAA ... "Atropine mixture with pralidoxime chloride". Drug Information Portal. U.S. National Library of Medicine. Portal: Medicine ( ...
Atropine is a parasympathetic blocker. The common premedication dose for atropine is 0.01-0.02 mg/kg. With standard intravenous ... Atropine is a muscarinic receptor antagonist, thus blocking the vagal response. The dose is 10 mcg/kg. It has quick onset of ... Atropine may also be used as a premedication agent in pediatrics to prevent bradycardia caused by hypoxia, laryngoscopy, and ... Atropine - The process of intubation can cause massive stimulation to vagus nerve, causing bradycardia (low heart rate). The ...
Atropine is administered for bradycardia. It acts on the vagus nerve so it's not effective in heart transplant patients as the ...
... bottles of Valium and atropine; several driver's licenses; a blue hooded parka; and underwear too small to fit Gacy. They also ...
... atropine, hyoscyamine, scopolamine, etc.) Anticonvulsants (topiramate, carbamazepine, lamotrigine, etc.) Antihistamines ( ...
The specific antidote is atropine. List of deadly fungi Carluccio A (2003). The Complete Mushroom Book. Quadrille. ISBN 1-84400 ...
The systematic name is atropine acylhydrolase. Other names in common use include tropine esterase, atropinase, and atropine ... Moog P, Krisch K (1974). "[The purification and characterization of atropine esterase from rabbit liver microsomes (author's ... The enzyme tropinesterase (EC 3.1.1.10) catalyzes the reaction atropine + H2O ⇌ {\displaystyle \rightleftharpoons } tropine + ...
The most common is called Atropine. Indirect-acting antagonist- drugs that inhibit the release/production of neurotransmitters ...
"Atropine - Myasthenia-gravis medicines and drugs". NHS Choices. 2014. Archived from the original on 12 July 2015. Retrieved 11 ... Another medication used for MG, atropine, can reduce the muscarinic side effects of acetylcholinesterase inhibitors. ...
The US Army has funded studies of the use of galantamine along with atropine in the treatment of a number of nerve agents, ... Increasing the dose of galantamine from 5 to 8 mg/kg decreased the dose of atropine needed to protect experimental animals from ... The use of a fast-acting peripheral anticholinergic drug such as atropine can block the receptors where acetylcholine acts to ... In the treatment of nerve agent poisoning, atropine is most often administered along with a Hagedorn oxime such as pralidoxime ...
"Atropine and bradycardia after myocardial infarction". Kounis NG, Chopra RK. Ann Intern Med 1974; 81: 117-8. "Oxytetracycline- ...
The mydriatic of choice is atropine. In the periods between acute attacks, no therapy has been shown to be beneficial. Horses ...
... treatment to speed it may include atropine. The corticosteroid medication methylprednisolone has been studied for use in SCI ...
Paton, W.D.M.; Rang, H.P. (1965). "The Uptake of Atropine and Related Drugs by Intestinal Smooth Muscle of the Guinea-Pig in ... Clark, A.J. (1926). "The antagonism of acetyl choline by atropine". Journal of Physiology. 61 (4): 547-546. doi:10.1113/ ...
Pharmacological treatments as; gabapentin, pregabalin, neostigmine/atropine, methylxanthines, and triptans. Minimally invasive ... "Addition of Neostigmine and Atropine to Conventional Management of Postdural Puncture Headache: A Randomized Controlled Trial ...
Atropine can be given when children produce a vagal response, evidenced by bradycardia, in response to intubation. Some ... Pretreatment includes 100% oxygen, lidocaine, and atropine. 100% oxygen should be administered for 3 to 5 minutes. The time ...
This pathway will be inhibited by atropine. Gastrin is transferred from a specific type of G cell in the gastric epithelium to ... which is of particular importance because the administration of atropine will not block the vagal stimulation of the G cells, ...
Injections of atropine are used in the treatment of symptomatic or unstable bradycardia. Atropine was previously included in ... Atropine or diphenhydramine can be used to treat muscarine intoxication.[medical citation needed] Atropine has been observed to ... atropine is poisonous.[medical citation needed] Atropine is sometimes added to potentially addictive drugs, particularly ... Even though atropine has not been officially indicated for either of these purposes by the FDA, it has been used by physicians ...
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE- diphenoxylate hydrochloride and atropine sulfate tablet Direct Rx. ... Atropine sulfate, an anticholinergic, is endo-(±)-α-(hydroxymethyl) benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1] oct-3-yl ... The following atropine sulfate effects are listed in decreasing order of severity, but not of frequency: hyperthermia, ... Since a subtherapeutic dose of atropine has been added to the diphenoxylate hydrochloride, consideration should be given to the ...
Detailed drug Information for Isopto Atropine. Includes common brand names, drug descriptions, warnings, side effects and ... Isopto Atropine (Ophthalmic). Generic name: atropine sulfate [ AT-roe-peen-SUL-fate ]. Drug class: Mydriatics ... Detailed Isopto Atropine dosage information Precautions while using Isopto Atropine. Your eye doctor will check your or your ... Uses for Isopto Atropine. Atropine sulfate eye drops is used to dilate the pupil before eye exams. It is also used to treat an ...
ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) ATROPINE SULFATE. 0.4 mg in 1 mL. ... ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) ATROPINE SULFATE. 1 mg in 1 mL. ... The major metabolites of atropine are noratropine, atropin-n-oxide, tropine, and tropic acid. The metabolism of atropine is ... Trace amounts of atropine have been reported in human milk after oral intake. There are no available data on atropine levels in ...
Atropine slows the heart rate, and was used to dry up fluids in the mouth to mitigate the risk of the boys choking on their own ... The Thai boys who were trapped in a cave last summer were given ketamine, xanax, and saliva suppressant atropine to stop them ... They were heavily sedated with ketamine, xanax, and atropine - a saliva suppressant - before cave divers pulled them out of the ...
Atropine Ophthalmic Atropine Care 1% ... Isopto® Atropine ... Ophthalmic atropine is used before eye examinations to dilate ( ... Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and ... Atropine has been added to diphenoxylate tablets to cause ... and pharmacist if you are allergic to diphenoxylate, atropine, ... They are: Atropine Diphenoxylate (an opioid) ... Medicines with these names contain atropine and diphenoxylate: Lofene Logen ...
Although low-dose atropine has shown promise for myopia control in children, the responses to treatment vary widely. In the Low ... Although low-dose atropine has shown promise for myopia control in children, the responses to treatment vary widely. In the Low ... Although age and atropine concentration were significant risk factors for SE progression and AL elongation, there was no ... All concentrations of atropine were well tolerated, regardless of age. The mean accommodation amplitude de-creased with age, ...
Here, we show that myopia-prevention by atropine requires production of nitric oxide (NO). Form-deprivation myopia (FDM) was ... Atropine inhibits myopia progression, but its mechanism is unknown. ... Atropine inhibited FDM as expected; adding NOS-inhibitors (L-NIO, L-NMMA) to atropine inhibited this effect dose-dependently, ... Atropine inhibits myopia progression, but its mechanism is unknown. Here, we show that myopia-prevention by atropine requires ...
Will atropine cause permanent dry mouth? My dog was put under while her ears where checked and cleaned. She was given atropine ... Atropine is removed from the body by the liver and kidneys. Since it took so long for your dog to recover from the drugs that ... Both the loss of balance and dry mouth that you describe are potential side effects of atropine administration. These effects ...
Atropine Ophthalmic Ointment 3.5gm. $39.08 Prescription items are NON-RETURNABLE and NON REFUNDABLE Atropine Sulfate Ophthalmic ... Prescription items are NON-RETURNABLE and NON REFUNDABLE Atropine Sulfate Ophthalmic Atropine Ophthalmic Ointment 1% is a ... Usage: Atropine should be instilled as directed by your veterinarian. Do not touch the dropper or tube opening to any surface, ... Benefits: Atropine is used to controls pain due to corneal and uveal disease. For use: Dogs, cats & horses Strength/Size: 1% ...
A03BA01 - Atropine*A07DA01 - Diphenoxylate*S01FA01 - Atropine. Pharmaceutical companies: manufacturers, researchers, developers ... Solution; Oral; Atropine Sulfate 0.025 mg; Diphenoxylate Hydrochloride 2.5 mg / 5 ml. ...
Clinical findings against which to titrate atropine dosage. Preferred routes of administration of atropine. Type of ... cholinesterase inhibitor toxicity that may require extremely high doses of atropine. ... Describing Mechanism by which atropine counters the effects of the cholinergic toxidrome. ... Diagnostic Use: The "Atropine Challenge". A number of authors have recommended the "atropine challenge" as an aid to diagnosis. ...
The goal of atropine administration is to improve conduction through the AVN by reducing vagal tone via atropine-induced ... Symptomatic patients should be treated with atropine and transcutaneous pacing. However, atropine should be administered with ... Atropine and Transcutaneous/Transvenous Pacing. Mobitz I block. Admit patients who have symptoms or who have concomitant acute ... Patients with infranodal second-degree AV block are unlikely to benefit from atropine. In addition, in patients who have ...
Get the best prices on Atropine sulfate eye drops pet medications today from Vet Depot. No Atropine coupons needed. ... Buy discount Atropine for dogs and cats at the cheapest prices. ... Do not use Atropine on animals with a known allergy to it or to ... Atropine is a prescription pet medication that is used as a mydriatic to dilate the pupils and as a cycloplegic to help control ... Atropine Sulfate is intended for use on animals only. Use this medication only on the animal for which it was prescribed. Do ...
Donnez-nous votre avis TRILIFAN RETARD 100 mg/1 ml solution injectable Introduction dans BIAM : 18/2/1992 Dernière mise à jour : 11/2/2000 Identification de la spécialité Présentation et Conditionnement Composition Propriétés Thérapeutiques Indications Thérapeutiques Effets secondaires Précautions demploi Contre-Indications Surdosage Voies dadministration Posologie et mode dadministration Identification de la spécialité Forme : SOLUTION INJECTABLE effet retard…. ...
Eyecare professionals can prescribe atropine for individual patients online at atropine.com or by calling ImprimisRx Customer ... "Our compounded atropine formulations undergo a strict series of validated analytical tests to ensure consistency, potency, and ... Healthcare providers may sign up for updates on the availability of atropine formulations through the ImprimisRx FDA-registered ... Harrow today announced the launch of atropine.com, an ordering and marketing portal that is designed specifically for ...
Material/Methods: Five adult mongrel dogs received endotracheal vasopressin(1.0 U/kg) with or without endotracheal atropine ( ... We investigated whether pre-treatment with atropine abrogates vasopressin-induced bradycardiain a beating-heart canine model. ... Atropine aborts bradycardic effect of endotracheally administered vasopressin. Med Sci Monit 2005; 11(9): CR410-414 :: ID: ...
Two studies presented at AAO demonstrate that low dose atropine is associated with slowing myopia progression, but another ... Another study on myopia and atropine presented alongside Bells study showed low-dose atropine works best in children , 10 ... The study was a pooled analysis of 187 children with myopia and were split up randomly into the nightly 0.01% atropine group or ... "We found that low-dose atropine is suitable for all children with myopia, regardless of age, sex, race, iris color, or baseline ...
Generic Atropine Sulfate and Canada prescription drugs from our generic pharmacy Blue Sky. Buy Atropine online or toll-free: ... Atropine (Atropine Sulfate) Product. Manufacturer. Country. Dosage. Qty. Price(USD). Atropine 10 x 1ml Ampules Injection. ... Buy Atropine online and generic Atropine with a prescription required at Canadian pharmacy. Our generic pharmacy provides a ... Atropine 10 x 1ml Ampules Injection. Teligent Canada Inc.. Canada. 0.6 mg/ml. 1. $67.99. ...
... low dose atropine 0.01%) for the treatment of children with myopia. ... Low Dose Atropine Eye Drops Under Review for Pediatric Myopia. Brian Park, PharmD ... The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for NVK002 (low dose atropine ... Close more info about Low Dose Atropine Eye Drops Under Review for Pediatric Myopia ...
Buy Isopto Atropine Online from North Drugstore. Low Prices Guaranteed. ... Full information about Isopto Atropine General Information on Isopto Atropine. Isopto Atropine is used for dilating the pupil ... Dosage of Isopto Atropine. The exact dosage of Isopto Atropine varies from patient to patient. Your doctor will prescribe you ... You need a doctors prescription to buy Isopto Atropine as it is a prescription-based drug. Isopto Atropine may also be used ...
Minims Atropine Sulphate 1%w/v, Eye drops solution Minims Atropine Sulphate 1%w/v, Eye drops solution *. Pharmacy Only: ...
Atropine eye drops do not slow myopia progression in US study ... The researchers found that nightly low-dose atropine did not ... New research published in JAMA Ophthalmology has found 0.01% atropine eye drops did not slow myopia progression in a group of ... US trial finds 0.01% atropine does not slow myopia progression. A study involving 187 children in the US found nightly low dose ... Over a two-year study period, participants were randomly assigned to instil either a drop of 0.01% atropine each night or a ...
Childhood Myopia and the use of atrophine eye drops to slow down the progression of of myopia in children. Singapore National Eye Centre shares more on the prevention of myopia and myopic progression.
... atropine-pralidoxime), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ... encoded search term (atropine/pralidoxime (ATNAA%2C DuoDote)) and atropine/pralidoxime (ATNAA, DuoDote) What to Read Next on ... atropine IV/IM. Monitor Closely (1)atropine IV/IM and pralidoxime both decrease cholinergic effects/transmission. Use Caution/ ... atropine decreases levels of droperidol by pharmacodynamic antagonism. Use Caution/Monitor.. atropine decreases levels of ...
Myopia ( nearsightedness ) is becoming more prevalent in children around the world. Asia has been the epicentre of this myopia epidemic and the situation seems to have worsened during this Covid-19 pandemic when many school children are engaging in more online educational activities. As a parent, you might be wondering if theres a cure […]. ...
View Atropine from sacred datura, devils weed, 2005 by Joyce Campbell at Two Rooms in Auckland, New Zealand. Discover more ... Atropine from sacred datura, devils weed, 2005. Hand printed gelatin silver fibre-based prints from Ambrotypes, edition of 5 ...
A publicly available article also appearing in PubMed about Atropine ... Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic ... Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic ... If there is no improvement in the clinical state after repeat doses of atropine, additional treatments with atropine are ...
Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic ... Atropine acts as a competitive, reversible antagonist of muscarinic receptors: an anticholinergic drug. This activity outlines ...
Bradycardia after Myocardial Ischemia and Its Treatment with Atropine Paul Dauchot, M.D; Paul Dauchot, M.D ... Oral Clonidine Premedication Blunts the Heart Rate Response to Intravenous Atropine in Awake Children Anesthesiology (May 1995) ... Paul Dauchot, J. S. Gravenstein; Bradycardia after Myocardial Ischemia and Its Treatment with Atropine. Anesthesiology 1976; 44 ... Effects of Oral Clonidine on Heart Rate Changes after Neostigmine-Atropine Administration Anesthesiology (June 1998) ...
  • The lower dose of 0.01% is thus generally recommended due to fewer side effects and potential less rebound worsening when the atropine is stopped. (wikipedia.org)
  • Patients were categorized by age (4-6 years, 7-9 years, and 10-12 years) and were assigned randomly to receive atropine 0.05%, 0.025%, 0.01%, or placebo. (aao.org)
  • The study was a pooled analysis of 187 children with myopia and were split up randomly into the nightly 0.01% atropine group or the placebo group for 2 years. (hcplive.com)
  • A trial conducted by Pediatric Eye Disease Investigator Group (PEDIG) showed mixed results, finding low-dose atropine eyedrops (concentration 0.01%) did not do a better job than placebo at myopia progression. (hcplive.com)
  • The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for NVK002 (low dose atropine 0.01%) for the treatment of children with myopia. (empr.com)
  • New research published in JAMA Ophthalmology has found 0.01% atropine eye drops did not slow myopia progression in a group of 187 US children. (aop.org.uk)
  • Over a two-year study period, participants were randomly assigned to instil either a drop of 0.01% atropine each night or a placebo eye drop. (aop.org.uk)
  • Evaluation of the Levels of Low-dose Topical Atropine (0.01%) in Aqueous and Vitreous Humor in Human Eyes. (bvsalud.org)
  • This is the first human study that confirmed penetration of 0.01% topical atropine in aqueous and vitreous humor in live human eyes . (bvsalud.org)
  • The purpose of this study was to evaluate penetration of low- dose atropine 0.01% in aqueous and vitreous humor . (bvsalud.org)
  • One drop of 0.01% atropine was put in the eye to be operated. (bvsalud.org)
  • Measurable concentration of low- dose topical atropine (0.01%) was noted in aqueous and vitreous humor after instillation of a single drop of low- dose atropine . (bvsalud.org)
  • Atropine sulfate eye drops is used to dilate the pupil before eye exams. (drugs.com)
  • Use of atropine sulfate eye drops in children younger than 3 months old is not recommended. (drugs.com)
  • Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of atropine sulfate eye drops in the elderly. (drugs.com)
  • They also highlighted that there could be racial differences in response to atropine eye drops. (aop.org.uk)
  • Given the use of pilocarpine as an antidote to atropine poisoning, Miss Marple ascertains that the husband's elderly father had actually committed the murder by emptying his bottle of eye drops (containing atropine sulfate) into his son's water glass. (christiesmysteries.com)
  • How can atropine eye drops slow down the progression of my child's myopia? (amplifyeye.care)
  • In addition to other available options for treating childhood myopia , one increasingly popular way to slow the progression is the use of low concentration atropine drops. (amplifyeye.care)
  • Are low dose atropine drops a cure for slowing progression in childhood nearsightedness? (amplifyeye.care)
  • Low-dose atropine eye drops is an effective approach to slowing the progression of myopia in children who are 5 to 15 years of age. (scotteye.com)
  • So next time you're about to reach for another bottle of Atropine 1% or whatever you've got on your shelf, remember that there's an alternative pathway to teardom that doesn't involve medicated drops. (godseesyourtears.com)
  • Chronic diarrhea in Crohn disease responds well to antidiarrheal agents such as loperamide (2-4 mg), diphenoxylate with atropine (1 tablet), and tincture of opium (8-15 drops). (medscape.com)
  • Isopto Atropine is used for dilating the pupil before an eye examination and for treating certain inflammation conditions related to eye. (northdrugstore.com)
  • Isopto Atropine dilates the eye by inhibiting the muscarinics receptors, which control the pupil size. (northdrugstore.com)
  • You need a doctor's prescription to buy Isopto Atropine as it is a prescription-based drug. (northdrugstore.com)
  • Isopto Atropine may also be used for medical purposes that are not mentioned above. (northdrugstore.com)
  • Isopto Atropine is contraindicated in patients with a known hypersensitivity to any ingredient used in the drug. (northdrugstore.com)
  • Like other drugs, Isopto Atropine may also cause certain side effects. (northdrugstore.com)
  • Some of the known side effects of Isopto Atropine are: watering eyes, blurred vision, and increased sensitivity to bright light, mild irritation, and red eye. (northdrugstore.com)
  • If you wear contact lenses, remove them before using Isopto Atropine. (northdrugstore.com)
  • After administering Isopto Atropine wait for, at least, 15-20 minutes before reinserting contact lenses. (northdrugstore.com)
  • The safety of Isopto Atropine in pregnant women has not been confirmed. (northdrugstore.com)
  • Contents of Isopto Atropine may enter breast milk and cause harm to a nursing baby. (northdrugstore.com)
  • Isopto Atropine should be used cautiously in elderly patients, patients who have raised intraocular pressure, and infants younger than 3 months. (northdrugstore.com)
  • Isopto Atropine may, in rare cases, cause side effects other than the ones listed here. (northdrugstore.com)
  • To know all other possible side effects of this drug, consult your doctor or read the patient information leaflet that you receive when you buy Isopto Atropine. (northdrugstore.com)
  • The exact dosage of Isopto Atropine varies from patient to patient. (northdrugstore.com)
  • Remember that Atropine is in part of a competitive landscape with Acetylcholine (ACH) - the main neurotransmitter of the parasympathetic nervous system. (passwithpass.com)
  • All doses of atropine appear similarly effective, while higher doses have greater side effects. (wikipedia.org)
  • Type of cholinesterase inhibitor toxicity that may require extremely high doses of atropine. (cdc.gov)
  • 2002) Thus, even when given sufficient doses of atropine, patients may need artificial ventilation, sometimes for weeks. (cdc.gov)
  • Some cases of mild to moderate poisonings may improve with these doses of atropine. (cdc.gov)
  • One author suggest avoiding large doses of pre-mixed atropine containing alcohol preservatives in children out of concern that alcohol toxicity could complicate the situation. (cdc.gov)
  • Pediatrics have previously used stronger doses of atropine (concentration: 0.5-1.0%) to slow myopia progression, but the dose leaves side effects such as light sensitivity and blurry near vision. (hcplive.com)
  • 2 Thus, investigators wanted to see if lower atropine doses could be effective. (hcplive.com)
  • If there is no improvement in the clinical state after repeat doses of atropine, additional treatments with atropine are unlikely to be effective. (statpearls.com)
  • Atropine was used in cardiopulmonary resuscitation in asystole and pulseless electrical activity (PEA) , doses of 0.5 to a maximum of 3 mg were administered intravenously. (zxc.wiki)
  • If Atropine is given slowly (or in low doses) to correct a bradycardia, it could paradoxically accentuate the parasympathetic actions of ACH - so therefore ACH would be considered the victor and thus the heart rate would continue to be slow or potentially get worse. (passwithpass.com)
  • However, by blocking the action of acetylcholine at muscarinic receptors, atropine also serves as a treatment for poisoning by organophosphate insecticides and nerve agents, such as tabun (GA), sarin (GB), soman (GD), and VX. (wikipedia.org)
  • Atropine can be used to reduce the effect of the poisoning by blocking muscarinic acetylcholine receptors, which would otherwise be overstimulated, by excessive acetylcholine accumulation. (wikipedia.org)
  • Atropine works by competitively occupying muscarinic receptor sites, thus reducing the effects of excessive acetylcholine on these sites brought about by cholinesterase inhibition. (cdc.gov)
  • Atropine is an antimuscarinic that works through competitive inhibition of postganglionic acetylcholine receptors and direct vagolytic action, which leads to parasympathetic inhibition of the acetylcholine receptors in smooth muscle. (statpearls.com)
  • Atropine sulfate blocks the muscarinic effects of acetylcholine that cause bronchorrhoea, hypersalivation, bronchoconstriction and bradycardia, thereby reducing these effects. (who.int)
  • Limit the total dose of atropine sulfate to 0.03 to 0.04 mg/kg [see Warnings and Precautions (5.1) ]. (nih.gov)
  • Unless recommended otherwise by the veterinarian, pharmacological dose of atropine sulfate is between 0.03 - 0.2 mg/kg. (teknovet.com.tr)
  • These results suggest that among the factors studied, age was the only predictor of response to atropine treatment. (aao.org)
  • Growing Body of Research Suggests Low-Dose Atropine Can Help Slow Myopia Progression in Children. (hcplive.com)
  • The researchers found that nightly low-dose atropine did not slow myopia progression when compared to placebo. (aop.org.uk)
  • Injections of atropine are used in the treatment of symptomatic or unstable bradycardia. (wikipedia.org)
  • If the patient is symptomatic, standard advanced cardiac life support (ACLS) guidelines for bradycardia, including the use of atropine and transcutaneous pacing, are indicated. (medscape.com)
  • Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic poisoning, and bradycardia. (statpearls.com)
  • Intravenous (IV) atropine indications include patients with hypersalivation, bronchial secretions, or bradycardia. (statpearls.com)
  • Atropine is the first-line therapy (Class IIa) for symptomatic bradycardia in the absence of reversible causes. (statpearls.com)
  • If bradycardia persists despite adequate respiratory support, atropine is indicated. (statpearls.com)
  • Although not recommended as a routine agent, atropine may be used 3 to 5 minutes before initiation of RSI to prevent bradycardia. (statpearls.com)
  • In the setting of post-intubation-related bradycardia, atropine is indicated. (statpearls.com)
  • Under current ACLS protocols, atropine is indicated for symptomatic bradycardia and not in a pulseless patient. (statpearls.com)
  • Atropine lives in your protocol for various ailments including symptomatic bradycardia and for rarer occurrences of organophosphate poisoning. (passwithpass.com)
  • If the bradycardia is persistent and the patient is symptomatic with signs of AMS, hypotension, or signs of shock, give Atropine in a 1 mg bolus (repeat to a 3 mg max if necessary) If this is ineffective consider TCP and/or vasopressors. (passwithpass.com)
  • Atropine is a tropane alkaloid and anticholinergic medication used to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate, and to decrease saliva production during surgery. (wikipedia.org)
  • Atropine acts as a competitive, reversible antagonist of muscarinic receptors: an anticholinergic drug. (statpearls.com)
  • Atropine/diphenoxylate is an antimotility agent that can be useful in the treatment of diarrhea as second-line therapy by allowing the central-acting opioid effect of diphenoxylate and capitalization on its anticholinergic side effect of constipation to slow motility. (statpearls.com)
  • Atropine is commonly classified as an anticholinergic or anti-parasympathetic (parasympatholytic) drug. (passwithpass.com)
  • Although age and atropine concentration were significant risk factors for SE progression and AL elongation, there was no interaction between the two, indicating that they influence myopia progression inde-pendently. (aao.org)
  • Atropine inhibits myopia progression, but its mechanism is unknown. (nih.gov)
  • Two studies presented at AAO demonstrate that low dose atropine is associated with slowing myopia progression, but another study finds that this is not true. (hcplive.com)
  • Darren J. Bell, MD, of the Medical Center Ophthalmology Associates in Texas presented the Phase III CHAMP (Childhood Atropine for Myopia Progression), a landmark, 3-year, placebo-controlled international clinical study, which showed lose-dose atropine is effective in slowing progression in children aged 3 - 17 years old who live in the U.S. and European Union. (hcplive.com)
  • Low-dose Atropine Eyedrops No Better Than Placebo for Showing Myopia Progression. (hcplive.com)
  • The results of the study differ from five clinical trials in East Asian and South Asian populations with similar age and refractive error which found beneficial effects of atropine for limiting myopia progression. (aop.org.uk)
  • By reducing the eye's ability to change focus, atropine can help reduce focusing fatigue and eye strain, which are commonly thought to influence the progression of myopia. (eyedrlinwang.com)
  • What is Atropine?Atropine is a once-a-week eye drop therapy which reduces spectacle prescription power and myopia progression in children. (myopia.com.sg)
  • Teknovet Atropin Injectable Solution is a clear, colorless, sterile solution. (teknovet.com.tr)
  • 0.4 mg/mL: containing 0.4 mg of atropine sulfate monohydrate equivalent to 0.332 mg of atropine. (nih.gov)
  • The 127th annual meeting of the American Academy of Ophthalmology (AAO) presented 3 studies on November 5th examining the relationship between myopia and atropine. (hcplive.com)
  • Mechanism by which atropine counters the effects of the cholinergic toxidrome. (cdc.gov)
  • Identify the mechanism of action of atropine. (statpearls.com)
  • Atropine degrades slowly, typically wearing off in 7 to 14 days, so it is generally used as a therapeutic mydriatic, whereas tropicamide (a shorter-acting cholinergic antagonist) or phenylephrine (an α-adrenergic agonist) is preferred as an aid to ophthalmic examination. (wikipedia.org)
  • The generic name of this drug is Atropine Ophthalmic. (northdrugstore.com)
  • 2023. https://www.nih.gov/news-events/news-releases/low-dose-atropine-eyedrops-no-better-placebo-slowing-myopia-progression#:~:text=Much%20stronger%20concentrations%20of%20atropine,while%20on%20the%20nightly%20eyedrops . (hcplive.com)
  • All concentrations of atropine were well tolerated, regardless of age. (aao.org)
  • Future studies of pharmacologic myopia control in US children should consider increased atropine concentrations, new pharmaceuticals, objective measures of treatment adherence, alternative eye drop delivery systems and schedules, as well as evaluating the impact of environmental and genetic factors and optical interventions on myopia control treatment," the authors concluded. (aop.org.uk)
  • Clinical findings against which to titrate atropine dosage. (cdc.gov)
  • Subtherapeutic amounts of atropine are included in the dosage form to discourage diphenoxylate abuse. (statpearls.com)
  • Although low-dose atropine has shown promise for myopia control in children, the responses to treatment vary widely. (aao.org)
  • Except for the use of atropine in selected cases of transient AV block, permanent cardiac pacing has replaced medical interventions in the treatment of patients with symptomatic, otherwise untreatable, AV block. (medscape.com)
  • However, transient improvements with repeat dosing are an indication to continue treatment with atropine (which may exceed standard cumulative dosing maximums). (statpearls.com)
  • What is Atropine Treatment for Nearsightedness in Children? (amplifyeye.care)
  • Atropine treatment is relatively simple. (amplifyeye.care)
  • Additional treatment included a continuous atropine infusion of 9 mg per hour for 5 days and a pralidoxime infusion (500 mg per hour) to a total of 26 g before ventilatory support could be discontinued. (cdc.gov)
  • We found that low-dose atropine is suitable for all children with myopia, regardless of age, sex, race, iris color, or baseline spherical equivalent refraction," Bell said in a news release. (hcplive.com)
  • Weekend Atropine Eyedrops (1%) Therapy Controls Childhood Myopia The eyes of today's children have no time to relax. (myopia.com.sg)
  • Moreover, Baum pointed out in the statement that while Harrow's current suite of compounded atropine formulations is available for individual patients through the ImprimisRx 503A national mail-order pharmacy, the comapny intends to make a patent‑pending suite of compounded atropine formulations that does not contain either preservatives or boric acid. (ophthalmologytimes.com)
  • Atropine Sulfate is an anti-muscarinic and works by blocking receptors in the eye muscles that are involved in controlling the shape of the lens and the size of the pupils. (vetdepot.com)
  • Topical atropine is used as a cycloplegic, to temporarily paralyze the accommodation reflex, and as a mydriatic, to dilate the pupils. (wikipedia.org)
  • Atropine is a prescription pet medication that is used as a mydriatic to dilate the pupils and as a cycloplegic to help control pain associated with corneal or uveal disease. (vetdepot.com)
  • In the second year, those initially given placebo received 0.05% atropine. (aao.org)
  • Atropine Sulfate dilates your pet's pupils prior to eye examinations. (vetdepot.com)
  • 4. Pretreatment (30 min) with the non-selective muscarinic antagonists scopolamine (0.1, 0.3 or 1 mg kg(-1), i.p.) and atropine (0.3, 1 or 3 mg kg(-1), s.c.) but not methylatropine (1, 3 or 10 mg kg(-1), s.c) significantly inhibited stretching induced by Ro 04-6790 (30 mg kg(-1), i.p.). 5. (lookformedical.com)
  • Troops who are likely to be attacked with chemical weapons often carry autoinjectors with atropine and an oxime, for rapid injection into the muscles of the thigh. (wikipedia.org)
  • Automatic injectors: the U.S. Armed Forces uses autoinjectors, containing 2 mg of atropine. (cdc.gov)
  • These atropine autoinjectors are packaged with a 2-PAM autoinjector, called Mark I kits. (cdc.gov)
  • A subtherapeutic amount of atropine sulfate is present to discourage deliberate overdosage. (nih.gov)
  • However, atropine should be administered with caution in patients with suspected myocardial ischemia, as ventricular dysrhythmias can occur in this situation. (medscape.com)
  • Muscarinic receptors located in the posterior segment such as the choroid and retina could be the possible site of action of low- dose atropine in myopia . (bvsalud.org)
  • Atropine is a muscarinic antagonist indicated for temporary blockade of severe or life threatening muscarinic effects. (nih.gov)
  • Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. (nih.gov)
  • Atropine is only useful to counter muscarinic effects (pralidoxime and benzodiazepines act on the others). (statpearls.com)
  • Atropine is often used in conjunction with the oxime pralidoxime chloride. (wikipedia.org)
  • Buy Atropine online and generic Atropine with a prescription required at Canadian pharmacy. (blueskydrugs.com)
  • Includes concepts that represent generic, human use, prescribable atropine and atropine in combination with other medications. (healthit.gov)
  • When the recurrent use of atropine is essential in patients with coronary artery disease, the total dose should be restricted to 2 to 3 mg (maximum 0.03 to 0.04 mg/kg) to avoid the detrimental effects of atropine-induced tachycardia on myocardial oxygen demand. (nih.gov)
  • The second peak was not affected by atropine pretreatment, but was blocked by pretreatment with CP-99. (lu.se)
  • A combination of atropine and CP-99 pretreatment abolished the mucociliary response to halothane. (lu.se)
  • Atropine pretreatment did not affect, whereas CP-99 significantly reduced, the response to desflurane. (lu.se)
  • These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. (nih.gov)
  • See full prescribing information for ATROPINE SULFATE INJECTION. (nih.gov)
  • Atropine Sulfate 15 mg, Sodium Chloride 9 mg, Benzyl Alcohol (preservative) 1%, Water for Injection q.s. (vetdepot.com)
  • The goal of atropine administration is to improve conduction through the AVN by reducing vagal tone via atropine-induced receptor blockade. (medscape.com)
  • Atropine was previously included in international resuscitation guidelines for use in cardiac arrest associated with asystole and PEA, but was removed from these guidelines in 2010 due to a lack of evidence for its effectiveness. (wikipedia.org)
  • In addition, in patients who have denervated hearts (eg, patients who have undergone a cardiac transplant), atropine is also not likely to be effective. (medscape.com)
  • The AHA has removed all indications for atropine in the pulseless patient. (statpearls.com)
  • Atropine aborts bradycardic effect of endotracheally administered vasopressin. (medscimonit.com)
  • Atropine is not an actual antidote for organophosphate poisoning. (wikipedia.org)
  • In summary, intraocular NO inhibits myopia dose-dependently and is obligatory for inhibition of myopia by atropine. (nih.gov)
  • Eyecare professionals can prescribe atropine for individual patients online at atropine.com or by calling ImprimisRx Customer Care at 844-446‑6979. (ophthalmologytimes.com)
  • Atropine can reduce the effects of cisapride. (nih.gov)
  • Both the loss of balance and dry mouth that you describe are potential side effects of atropine administration. (vetinfo.com)
  • While atropine can be used independently for anti-salivation effects, it is not formally recommended for routine use in controlled airways, though it can be used off-label for minimizing secretions in the intubated patient. (statpearls.com)
  • Medicinal products contain the drug atropine as a racemate (1: 1 mixture of the enantiomers), whereby the use of the enantiomer which is more effective or has fewer side effects would be preferable for fundamental reasons. (zxc.wiki)